<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id><journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id><journal-title-group><journal-title>Frontiers in Molecular Biosciences</journal-title></journal-title-group><issn pub-type="epub">2296-889X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098079</article-id><article-id pub-id-type="publisher-id">1571103</article-id><article-id pub-id-type="doi">10.3389/fmolb.2025.1571103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biosciences</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Metabolic insights into hypoxia adaptation in adolescent athletes at different altitudes: a cross-sectional study</article-title><alt-title alt-title-type="left-running-head">S&#x000e1;nchez et al.</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fmolb.2025.1571103" ext-link-type="uri">10.3389/fmolb.2025.1571103</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>S&#x000e1;nchez</surname><given-names>Carlos A. R.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pardo-Rodriguez</surname><given-names>Daniel</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2391932/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Mancera-Soto</surname><given-names>Erica</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/536775/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Le&#x000f3;n</surname><given-names>Lizeth</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Paulucio</surname><given-names>Dailson</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>Angelo</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/318400/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Caleb G. M.</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/568271/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Cristancho</surname><given-names>Edgar</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1860148/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Monnerat</surname><given-names>Gustavo</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/882669/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Ramos-Caballero</surname><given-names>Diana M.</given-names></name><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cala</surname><given-names>M&#x000f3;nica P.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1227339/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pompeu</surname><given-names>Fernando</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Federal University of Rio de Janeiro</institution>, <institution>Biometrics Laboratory (LADEBIO)</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Metabolomics Core Facility</institution>, <institution>Vice-Presidency for Research</institution>, <institution>Universidad de los Andes</institution>, <addr-line>Bogot&#x000e1;</addr-line>, <country>Colombia</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Departamento del Movimiento Corporal Humano</institution>, <institution>Facultad de Medicina</institution>, <institution>Universidad Nacional de Colombia</institution>, <addr-line>Bogot&#x000e1;</addr-line>, <country>Colombia</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Department of Biochemistry and Molecular Genetics</institution>, <institution>University of Colorado Denver-Anschutz Medical Campus</institution>, <addr-line>Aurora</addr-line>, <addr-line>CO</addr-line>, <country>United States</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Instituto de Biologia do Ex&#x000e9;rcito</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Departamento de Biolog&#x000ed;a</institution>, <institution>Facultad de Ciencias</institution>, <institution>Universidad Nacional de Colombia</institution>, <addr-line>Bogot&#x000e1;</addr-line>, <country>Colombia</country>
</aff><aff id="aff7">
<sup>7</sup>
<institution>Federal University of Rio de Janeiro</institution>, <institution>Institute of Biophysics Carlos Chagas Filho</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country>
</aff><aff id="aff8">
<sup>8</sup>
<institution>Escuela de Medicina y Ciencias de la Salud</institution>, <institution>Universidad del Rosario</institution>, <addr-line>Bogot&#x000e1;</addr-line>, <country>Colombia</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/268764/overview" ext-link-type="uri">Guillermo Moyna</ext-link>, Universidad de la Rep&#x000fa;blica, Uruguay</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/1189353/overview" ext-link-type="uri">Andres Lopez Radcenco</ext-link>, Universidad de la Rep&#x000fa;blica, Uruguay</p><p>
<ext-link xlink:href="https://loop.frontiersin.org/people/1279955/overview" ext-link-type="uri">Daniel Bia</ext-link>, Universidad de la Rep&#x000fa;blica, Uruguay</p></fn><corresp id="c001">*Correspondence: M&#x000f3;nica P. Cala, <email>mp.cala10@uniandes.edu.co</email>; Fernando Pompeu, <email>fpompeu@eefd.ufrj.br</email>
</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1571103</elocation-id><history><date date-type="received"><day>04</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 S&#x000e1;nchez, Pardo-Rodriguez, Mancera-Soto, Le&#x000f3;n, Paulucio, D&#x02019;Alessandro, Santos, Cristancho, Monnerat, Ramos-Caballero, Cala and Pompeu.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>S&#x000e1;nchez, Pardo-Rodriguez, Mancera-Soto, Le&#x000f3;n, Paulucio, D&#x02019;Alessandro, Santos, Cristancho, Monnerat, Ramos-Caballero, Cala and Pompeu</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Athletes use hypoxic training methods to enhance their performance under altitude conditions. Comparative studies involving populations from low (500&#x02013;2,000 m) and moderate (2,000&#x02013;3,000 m) altitudes offer an opportunity to understand the mechanisms behind adaptations to hypoxia. The present study combined data from metabolomics analysis based on gas- and liquid-chromatography mass spectrometry (GC-MS and LC-MS) to compare plasma profiles from 80 adolescent athletes at moderate- or low altitudes. 161 metabolites were identified, including 84 elevated and 77 decreased in moderate-altitude adolescents compared to their low-altitude counterparts. Pathway analysis revealed that metabolites related to carbohydrates, amino acids, and lipid metabolism differed between groups. Lipid metabolism was significantly altered in moderate-altitude athletes, including pathways such as linolenic and linoleic acid, sphingolipid, and arachidonic acid, as well as processes involving the transfer of acetyl groups into mitochondria and fatty acid biosynthesis. Biomarker analysis looking for signatures of chronic adaptation to moderate altitude identified glycerol and 5-oxoproline metabolites amongst the variables with the strongest sensitivity and specificity. This study demonstrates differences in metabolic profiles between moderate- and low-altitude populations and highlights the potential of these differential metabolites and associated metabolic pathways to provide new insights into the mechanisms of adaptation to moderate altitude.</p></abstract><kwd-group><kwd>untargeted metabolomics</kwd><kwd>altitude training</kwd><kwd>hypoxia</kwd><kwd>endurance exercise</kwd><kwd>adolescent</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This study was financially supported by the funds from the National Program of Projects for the strengthening of research, creation and innovation in postgraduate courses of the National University of Colombia in the editions of 2013&#x02013;2015 and 2016&#x02013;2018. We also received funding from the Central Unit of the Valley (UCEVA, Colombia) for conducting the research in Tulu&#x000e1;.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Metabolomics</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>1 Introduction</title><p>Biological maturation is a key factor influencing variations in maximum oxygen consumption (VO<sub>2max</sub>) throughout human development (<xref rid="B55" ref-type="bibr">Mancera-Soto et al., 2022a</xref>; <xref rid="B56" ref-type="bibr">Mancera-Soto et al., 2022b</xref>; <xref rid="B57" ref-type="bibr">Mancera-Soto et al., 2021</xref>). Endurance training induces changes in the human body&#x02019;s structure and function. This leads to concurrent adaptations in various physiological systems, such as the cardiovascular, hematological, and musculoskeletal systems. These adaptations contribute to an enhanced VO<sub>2max</sub> and improvements in work capacity (<xref rid="B37" ref-type="bibr">Jones and Carter, 2000</xref>). For endurance sports, the primary limiting factor for VO<sub>2max</sub> (<xref rid="B99" ref-type="bibr">Xavier et al., 2019</xref>) is the supply of oxygen to active muscles and effective energy management. Since oxygen is carried by hemoglobin, both total hemoglobin mass (Hbt) and blood volume (BV) play crucial roles in determining the oxygen transport capacity in the blood, consequently influencing VO<sub>2max</sub> (<xref rid="B81" ref-type="bibr">Schmidt and Prommer, 2010</xref>). Transition from childhood to adolescence is facilitated by hormonal changes, among which elevation in testosterone levels, especially in males, promotes musculoskeletal growth and erythropoiesis (<xref rid="B78" ref-type="bibr">Roy et al., 2023</xref>). Various factors, including altitude and physical training, can alter the oxygen transport capacity (<xref rid="B55" ref-type="bibr">Mancera-Soto et al., 2022a</xref>). Exposure to altitude induces specific biological effects in humans, amongst which one of the earliest and most established cascades involves the activation of hypoxia-responsive elements (e.g., hypoxia-inducible factors&#x02013;HIF-1&#x003b1; and HIF-2&#x003b1;) (<xref rid="B82" ref-type="bibr">Semenza, 2001</xref>), the elevation of testosterone and erythropoietin to boost erythropoiesis (<xref rid="B50" ref-type="bibr">Lima et al., 2023</xref>). Rapid responses to environmental hypoxia trigger rapid cascades of metabolic (<xref rid="B93" ref-type="bibr">Travis et al., 2016</xref>) and cardiorespiratory changes that impact both the transport and utilization of oxygen (<xref rid="B100" ref-type="bibr">Xu et al., 2022</xref>), such as the rapid synthesis of allosteric modulators of hemoglobin that favor oxygen off-loading, such as 2,3-bisphosphoglycerate (<xref rid="B15" ref-type="bibr">D&#x02019;Alessandro et al., 2024</xref>) (BPG). Lipid metabolism, like the synthesis of sphingosine 1-phosphate, can further contribute to stabilizing BPG-bound deoxyhemoglobin (<xref rid="B89" ref-type="bibr">Sun et al., 2016</xref>; <xref rid="B88" ref-type="bibr">Sun et al., 2017</xref>), thus enhancing oxygen off-loading capacity and accelerating oxygen kinetics at a single cell level (<xref rid="B75" ref-type="bibr">Rabcuka et al., 2022</xref>). These adaptations are particularly relevant in athletes, with recent findings supporting the positive impact of altitude training on cardiorespiratory fitness parameters in young runners (<xref rid="B79" ref-type="bibr">Saltin et al., 1995</xref>). Other studies have demonstrated an increase in blood oxygen-related transport parameters through traditional altitude training methods (Live High: Train High or Live High: Train Low) in trained adolescents (<xref rid="B1" ref-type="bibr">Bahensk&#x000fd; et al., 2020</xref>; <xref rid="B12" ref-type="bibr">Christoulas et al., 2011</xref>). Similar trends have been observed from innovative LLTH (Live Low: Train High) methods, which result favorable hematological alterations in the total number of red blood cells or the total hemoglobin mass and enhance the activity of the transcription factor HIF-1&#x003b1; (<xref rid="B6" ref-type="bibr">Burtscher et al., 2022</xref>; <xref rid="B84" ref-type="bibr">Sharma et al., 2023</xref>).</p><p>As an increasing number of lowland children relocate to high altitudes (<xref rid="B73" ref-type="bibr">Pollard et al., 2001</xref>), studying physiological acclimatization to hypoxia and associated conditions becomes more crucial. It is essential to identify the molecular variables that play pivotal roles in this process to understand the mechanisms that counteract the adverse effects of oxygen deficiency. The physiological processes characterizing adaptation to acute and prolonged hypobaric hypoxia exposure at high altitudes encompass ventilation and cardiac function, hematology, and oxygen consumption. These processes aid the body in acclimating to hypoxic conditions. Additionally, hypoxia induces metabolic responses to align ATP synthesis and demand in response to decreased oxidative capacity and increased oxidative stress (<xref rid="B61" ref-type="bibr">Muza et al., 2010</xref>; <xref rid="B97" ref-type="bibr">West, 2015</xref>; <xref rid="B10" ref-type="bibr">Chicco et al., 2018</xref>). Studies investigating metabolic acclimatization in healthy human lowlanders have shown tissue-specific responses in skeletal muscle. These studies suggest a shift away from oxidative processes, including &#x003b2;-oxidation, tricarboxylic acid (TCA) cycle activity, and oxidative phosphorylation, towards increased reliance on carbohydrate metabolism (<xref rid="B34" ref-type="bibr">Horscroft and Murray, 2014</xref>; <xref rid="B10" ref-type="bibr">Chicco et al., 2018</xref>). Enhanced glycolytic capacity has been proposed due to increased levels of glycolytic intermediates within muscle tissue and the upregulation of glucose transporters and glycolytic enzymes mediated by HIF-1&#x003b1; (<xref rid="B33" ref-type="bibr">Horscroft et al., 2017</xref>; <xref rid="B42" ref-type="bibr">Kim et al., 2006</xref>; <xref rid="B83" ref-type="bibr">Semenza et al., 1994</xref>). In adults, adaptation to hypoxia involves the modulation of related metabolites, as demonstrated in previous research (<xref rid="B48" ref-type="bibr">Liao et al., 2016</xref>; <xref rid="B28" ref-type="bibr">Gao et al., 2023</xref>). Changes induced by hypoxia include alterations in lipid storage and mobilization, such as decreased circulating high-density lipoproteins, increased triglyceride concentrations, inhibited lipoprotein lipase activity, and suppressed <italic>de novo</italic> lipogenesis (<xref rid="B90" ref-type="bibr">Suzuki et al., 2014</xref>). These responses are likely regulated at the transcriptional level through HIF-1/2&#x003b1; and may be influenced by changes in circulating catecholamines, which stimulate lipolysis <italic>via</italic> hormone-sensitive lipase (<xref rid="B87" ref-type="bibr">Siervo et al., 2014</xref>). Furthermore, peroxisome proliferator-activated receptor alpha (PPAR&#x003b1;), a transcriptional regulator of fatty acid oxidation in the liver, heart, and muscle, has been identified as a key player in hypoxic metabolic remodeling processes (<xref rid="B14" ref-type="bibr">Cole et al., 2016</xref>).</p><p>Metabolomics is a discipline that studies small molecule metabolites (&#x0003c;2 kDa), which are the end-product of the enzymatic activity of gene products in a biological system (<xref rid="B8" ref-type="bibr">Carneiro et al., 2019</xref>). When applied to endurance sports, metabolomics can be a valuable tool for understanding how the body responds to acute, subacute, and chronic exercise and how athletes can optimize their performance and recovery (<xref rid="B36" ref-type="bibr">Jaguri et al., 2023</xref>; <xref rid="B62" ref-type="bibr">Nemkov et al., 2023a</xref>; <xref rid="B63" ref-type="bibr">Nemkov et al., 2023b</xref>; <xref rid="B65" ref-type="bibr">Nemkov et al., 2021</xref>; <xref rid="B59" ref-type="bibr">Monnerat et al., 2020</xref>). Simultaneously, metabolomics explores adaptive responses to hypoxia, seeking specific metabolites that could be early indicators for conditions like cardiovascular and lung diseases. Metabolomics has contributed to understanding the molecular mechanisms underlying the acute and chronic hypoxic response. This includes identifying altered metabolic pathways under hypoxic conditions and characterizing how these metabolic changes affect cellular functioning (<xref rid="B9" ref-type="bibr">Chang et al., 2019</xref>). Overall, most existing studies have aimed to comprehend the cardiorespiratory and hematological changes linked to altitude exposure. However, limited reports investigate moderate-altitude residents&#x02019; metabolic effects on adolescent endurance athletes&#x02019; metabolic profiles. Recent advances in metabolomic techniques make it possible to uncover plasma metabolic profiles in individuals, providing a better insight into hypoxia adaptation and the opportunity to understand the mechanisms of hypoxia resistance. Understanding around metabolic adaptations to hypoxia could serve to improve multiple aspects of optimizing training strategies, improving altitude acclimatization, and developing personalized approaches to enhance athletic performance and recovery. In this study, we conducted an untargeted metabolomics analysis using chromatographic methods coupled to time-of-flight mass spectrometry approaches to explore the metabolic profiles of trained endurance athletes residing at moderate altitude compared to age and sex-matched counterparts living at low altitude.</p></sec><sec sec-type="materials|methods" id="s2"><title>2 Materials and methods</title><sec id="s2-1"><title>2.1 Participants</title><p>The data for this study were collected as part of a larger observational study previously reported (<xref rid="B55" ref-type="bibr">Mancera-Soto et al., 2022a</xref>; <xref rid="B56" ref-type="bibr">Mancera-Soto et al., 2022b</xref>; <xref rid="B57" ref-type="bibr">Mancera-Soto et al., 2021</xref>). The study involved the analysis of 80 adolescent male athletes, with an average age of 15 &#x000b1; 2 years and VO<sub>2max</sub> of 56.6 &#x000b1; 7.7 mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>. These athletes specialized in aerobic endurance activities such as inline skating, athletics runners and cycling (<xref rid="s13" ref-type="sec">Supplementary Table S1</xref>) were classified as altitude natives (n = 40), or lowlanders (n = 40) based on their birthplace altitude (Bogot&#x000e1; &#x0223c;2,600 m and Tulu&#x000e1; &#x0223c;1,000 m). The sexual maturation stage of all participants was determined according to Tanner (<xref rid="B92" ref-type="bibr">Tanner, 1962</xref>), and only individuals classified as stage III, IV, or stage V were included in the study. Athletes with a minimum of 2 years of training experience, committing at least 6 h per week to training sessions, conducted at least 3 times per week. Additionally, participants were also required to have lived at their respective altitudes for a minimum of 5 years and not to have changed altitudes for more than 1 week during the preceding year. Participants with recent lower limb musculoskeletal injuries or who reported consuming iron, folic acid, or other supplements that potentially alter the study variables were not allowed to participate. All adolescents and their parents provided informed consent, the experimental procedures adhered to the Declaration of Helsinki (1964), and were approved by the ethical committee of the National University of Colombia at Bogot&#x000e1; (reference: ID 06/2015).</p></sec><sec id="s2-2"><title>2.2 Study design</title><p>This cross-sectional study with an independent group design was conducted at four-time points (T1&#x02013;T4). The evaluation included anthropometric measurements, medical examinations, and ergospirometry measurements following the protocols outlined by Mancera et al., in 2022 (<xref rid="B55" ref-type="bibr">Mancera-Soto et al., 2022a</xref>; <xref rid="B56" ref-type="bibr">Mancera-Soto et al., 2022b</xref>). Details are included as <xref rid="s13" ref-type="sec">Supplementary Material</xref>. On T1, anthropometric measurements, medical and fitness examinations, and biological maturation assessments were performed. On T2, a cubital venous blood sample of 4 mL of heparinized blood was obtained to determine hemoglobin concentration, hematocrit, reticulocyte count, and metabolomic parameters. In T3, hemoglobin mass was determined using the CO rebreathing method according to the protocols above (<xref rid="B80" ref-type="bibr">Schmidt and Prommer, 2005</xref>; <xref rid="B74" ref-type="bibr">Prommer and Schmidt, 2007</xref>). On T4, an incremental step test on a cycle ergometer or treadmill was performed to assess VO<sub>2max</sub>. All participants were instructed to abstain from strenuous physical activities (&#x0003e;5METs, defined as the resting metabolic rate) in the 24 h before the evaluations. To avoid methodological errors in the comparison of results, the same equipment was used in the low-altitude and moderate-altitude laboratories, and the same evaluators carried out the tests within a 2-week interval. Cyclists and skaters were tested on a cycle ergometer, and runners were tested on a treadmill. VO<sub>2max</sub> levels of athletics were adjusted using established correction methods described in the <xref rid="s13" ref-type="sec">Supplementary Material</xref>.</p></sec><sec id="s2-3"><title>2.3 Sample preparation</title><p>Plasma metabolites extraction was performed according to the reported methods with some modifications (<xref rid="B71" ref-type="bibr">Pardo-Rodriguez et al., 2023</xref>). Briefly, 100 &#x003bc;L of plasma were mixed with 300 &#x003bc;L iced-cold methanol:ethanol (1:1) and vortexed for 2 min (<xref rid="B102" ref-type="bibr">Yang et al., 2013</xref>). Then, samples were placed at &#x02212;20&#x000b0;C for 20 min and centrifuged at 10,000 &#x000d7; <italic>g</italic> for 10 min at 4&#x000b0;C. For GC-MS analysis, 20 &#x003bc;L of the previous extract was evaporated to dryness utilizing a speedvac tool for 90 min at 35&#x000b0;C. Methoxymation was performed by adding 10 &#x003bc;L of methoxyamine hydrochloride (15 mg/mL pyridine) and mixing for 5 min. Methoxymation was carried out at room temperature for 16 h. Samples were silylated at 70&#x000b0;C for 1 h with 10 &#x003bc;L of N, O-Bis(trimethylsilyl) trifluoroacetamide. Finally, 40 &#x000b5;L of heptane (containing 2 ppm of methyl stearate as an internal standard) were added (<xref rid="B24" ref-type="bibr">Fiehn, 2016</xref>).</p><sec id="s2-3-1"><title>2.3.1 Liquid chromatography-mass spectrometry (LC&#x02013;MS)</title><p>Metabolomic profiling analysis was conducted on an Agilent Technologies 1260 Liquid Chromatography system coupled to a quadrupole time-of-flight (QTOF) mass spectrometer using positive electrospray ionization mode. The chromatography separation of metabolites was performed by an InfinityLab Poroshell 120 EC-C18 (100 &#x000d7; 2.1 mm, 1.9 &#x000b5;m) column at 40&#x000b0;C, with an injection volume of 2 &#x003bc;L and a flow rate of 0.4 mL/min. Mobile phases were 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The gradient started at 5% B, and increased to 95% B from 0 to 15 min, and held there for 1 min, then returned to 5% B at 16.1 min and equilibrated there until 20 min. Parameters for mass spectrometry acquisition were as follows: Vcap (V) 3000, gas temp 250&#x000b0;C, drying gas 12 L/min, nebulizer 52 psi, sheat gas temp 370&#x000b0;C, sheat gas flow 11 L/min, fragmentor 175 V, skimmer 65 V and octapole radio frequency voltage of 750 V. Centroid data were collected from 100 to 1,100 m<italic>/z</italic> and a scan rate of 1.02 spectra/s. Mass accuracy was maintained by continuously monitoring internal reference ions, <italic>m/z</italic> 121.0509 (purine) and <italic>m/z</italic> 922.0098 (HP-0921).</p></sec><sec id="s2-3-2"><title>2.3.2 Gas chromatography-mass spectrometry (GC&#x02013;MS)</title><p>Samples were analyzed on Agilent Technologies 7890B gas chromatograph coupled to a 7250GC/Q-TOF time-of-flight mass spectrometer. 1 &#x003bc;L of the derivatized sample was injected with a constant gas flow of 0.7 mL/min and a split ratio of 30:1 onto a column HP-5MS (30 m, 0.25 mm, 0.25 &#x000b5;m) (Agilent Technologies). The oven temperature was programmed from 60&#x000b0;C for 1 min, then increased to 325&#x000b0;C with a ramp rate of 10&#x000b0;C/min and held there for 10 min. Mass spectra were recorded at 70 eV in full scan mode with values in the range of 50&#x02013;600 m<italic>/z</italic>. The temperature of the transfer line to the detector was 280&#x000b0;C, the source filament 230&#x000b0;C, and quadrupole temperature 150&#x000b0;C.</p></sec><sec id="s2-3-3"><title>2.3.3 Quality control samples</title><p>According to previously reported (<xref rid="B44" ref-type="bibr">Kirwan et al., 2022</xref>), quality control and quality assurance were implemented in this study to achieve reliable and consistent data.</p></sec><sec id="s2-3-4"><title>2.3.4 Data treatment</title><p>Raw files acquired from LC-MS were imported into <italic>Agilent MassHunter Profinder B.10.0</italic> software for feature extraction, using molecular feature extraction and recursive feature extraction algorithms. For GC/MS data, the Agilent Unknowns Analysis B.10.0, the MassProfiler Professional v15, and the Agilent MassHunter Quantitative Analysis B.10.00 software were used for the process of deconvolution, alignment, and integration, respectively. Features that were present in at least 80% of samples within the same group and had a coefficient of variation (CV, %) in QC samples below 20% for LC data (30% for GC data) were selected for statistical analysis.</p></sec><sec id="s2-3-5"><title>2.3.5 Statistical analysis of the clinical variables of the study participants</title><p>The statistical analyses were conducted using the software JASP (Version 0.17.1; JASP team, 2024). Data normality was assessed using the Shapiro-Wilk test. Variables that met normality assumptions were analyzed using parametric tests. The variables age, height, and training load (hours) did not meet normality assumptions and were compared between groups using the non-parametric Mann-Whitney test. The hematological, ergospirometry, and anthropometry parameters were analyzed using Student&#x02019;s t-test for independent samples. To evaluate the effects of the sports disciplines in the groups, one-way analysis of variance (ANOVA) for independent measures was run. A Bonferroni <italic>post hoc</italic> test was used for multiple comparisons when statistical differences were found. The dependent variables age (y), height (cm), body mass (kg), fat-free mass (kg), percent fat % and training load (hours) did not meet normality assumptions and were compared between the groups using the non-parametric Kruskal&#x02013;Wallis test. Effect sizes (ES) were calculated to compare altitude natives and lowlanders groups. Effect sizes of 0.10&#x02013;0.24, 0.25 to 0.40, and &#x0003e;0.40 were used to indicate small, medium, and large sizes (<xref rid="B13" ref-type="bibr">Cohen, 2013</xref>). Using the Spearman correlation method, significant metabolites were used to correlate with physiological, and hematological parameters. Descriptive statistics are reported as mean &#x000b1; standard deviation (SD). A level of &#x003b1; &#x02264; 0.05 was considered for statistical significance.</p></sec><sec id="s2-3-6"><title>2.3.6 Data processing and analysis</title><p>Univariate analysis (UVA) and multivariate analysis (MVA) statistical analyses were performed to identify the molecular features with statistically significant differences between groups. UVA p-values were calculated using nonparametric tests (Mann-Whitney U test) in software MATLAB Version: 9.13.0 (R2022b) Update 2 (<xref rid="B35" ref-type="bibr">Inc, 2022</xref>). PCA was employed as an unsupervised method in MVA analysis to evaluate data quality and sample distribution. The molecular features leading to group separation were identified using supervised orthogonal partial least squares regression approach (OPLS-DA) models. The quality and performance of the multivariate OPLS-DA models were evaluated using the <italic>R</italic>
<sup>2</sup>, <italic>Q</italic>
<sup>2</sup>, permutation test, and cross-validation analysis of variance values. MVA analysis was performed using the SIMCA-P+16.0 software (Umetrics). The statistically significant features chosen met at least one of the following requirements: (1) UVA&#x02014;p-value &#x0003c;0.05 and (2) MVA&#x02014;variance important in projection (VIP) &#x0003e; 1. The predictive performance of each selected biomarker was assessed through ROC analysis (<xref rid="s13" ref-type="sec">Supplementary Material</xref>).</p></sec><sec id="s2-3-7"><title>2.3.7 Metabolites identification</title><p>Multiple variables have been employed to annotate relevant characteristics analyzed with liquid chromatography. This includes confirming retention times and the probability of adduct formation, comparing high-resolution masses to database records using the CEU Mass Mediator tool, and developing theoretical formulations based on isotopic distributions. MS/MS data were compared to spectra data obtained from MS-DIAL 4.80, Lipid Annotator software v10.0, and the GNPS server. Manual interpretation of the MS/MS spectra was also carried out. Compound identification through GC analysis was accomplished by comparing the mass spectrum and FAMES retention index to those in the Fiehn GC-MS Metabolomics RTL Library 2013 (<xref rid="B43" ref-type="bibr">Kind et al., 2009</xref>). Each platform&#x02019;s identification levels were assigned based on Bla&#x0017e;enovi&#x00107; et al.'s Metabolomics Standards Initiative criteria (<xref rid="B4" ref-type="bibr">Bla&#x0017e;enovi&#x00107; et al., 2018</xref>).</p></sec><sec id="s2-3-8"><title>2.3.8 ROC curve analysis</title><p>ROC (Receiver Operating Characteristic) curve analysis was performed using GraphPad Prism (version 8.0.1, GraphPad Software, San Diego, CA, United States) to evaluate the discriminatory power of the selected metabolites. Only metabolites that met the statistical threshold of adjusted p-value (FDR) &#x0003c; 0.05 and had Level 2 identification confidence (according to the Metabolomics Standards Initiative) were included in the analysis. For each metabolite, the area under the curve (AUC) and its 95% confidence interval were calculated. In addition, the optimal cutoff point was determined based on the maximum Youden index (<italic>J</italic> = sensitivity + specificity&#x02212;1), which represents the best trade-off between sensitivity and specificity.</p></sec></sec></sec><sec sec-type="results" id="s3"><title>3 Results</title><sec id="s3-1"><title>3.1 Performance and physiological characteristics</title><p>The demographic characteristics of the altitude natives and lowlanders groups are outlined in <xref rid="T1" ref-type="table">Table 1</xref>. Both groups exhibited similar anthropometric features, except for body fat percentage, indicating distinctions in body composition. There were no significant differences in the weekly training volume between the altitude natives and lowlanders groups. Regarding physiological properties, the maximal heart rate achieved during the maximal exercise test varied between the groups. Relative VO<sub>2max</sub> and VO<sub>2maxLBM</sub> obtained in the incremental step test was 4.2 mL&#x02219;min [95% CI: (1.75, 6.75); p = 0.001] and 4.3 mL&#x02219;min [95% CI: (1.00, 7.60); p = 0.001] higher in altitude natives compared to lowlanders. Moreover, it is worth investigating whether the environmental conditions influence these results during the tests. To facilitate a meaningful comparison between the two groups, we adjusted the VO<sub>2max</sub> values of the participants from Tulu&#x000e1; to the predicted values for 2,600 m. This adjustment was made using understandings provided by <xref rid="B26" ref-type="bibr">Fulco et al. (1998)</xref>. According to their regression curves, we observed a 12% decrease in VO<sub>2max</sub> for participants with values &#x02264;51 mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup> and a 20% decrease for participants with values &#x02265;63 mL &#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>. Following this correction, the maximum oxygen consumption altitude (VO<sub>2maxalt</sub>) was found to be 12.1 mL&#x02219;min [95% CI: (10.00, 14.32); p = 0.001] higher in the altitude group compared to the lowlanders group. The respiratory quotient was not different between the altitude natives and the lowlanders groups. Significant differences were observed in body fat percentage (<italic>F</italic> = 5.731, p = 0.001) between athletic runners and participants in the inline skating and cycling groups. Additionally, the respiratory quotient (<italic>F</italic> = 19.375, p = 0.001) differed significantly between athletic runners and the cycling group (<xref rid="s13" ref-type="sec">Supplementary Table S1</xref>).</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Anthropometric, physiological, and hematological parameters of adolescent athletes participating in the present study.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th rowspan="2" align="center" colspan="1"/><th rowspan="2" align="center" colspan="1">Altitude natives<break/>Male = 40</th><th rowspan="2" align="center" colspan="1">Lowlanders<break/>Male = 40</th><th rowspan="2" align="center" colspan="1">p-value</th><th colspan="2" align="center" rowspan="1">95% CI for effect size</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower</th><th align="center" rowspan="1" colspan="1">Upper</th></tr></thead><tbody valign="top"><tr><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Anthropometric data</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Age (y)</td><td align="center" rowspan="1" colspan="1">15.6 &#x000b1; 1.7 (12&#x02013;18)</td><td align="center" rowspan="1" colspan="1">15.2 &#x000b1; 1.9 (10&#x02013;18)</td><td align="center" rowspan="1" colspan="1">0.383</td><td align="center" rowspan="1" colspan="1">&#x02212;0.143</td><td align="center" rowspan="1" colspan="1">0.350</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Height (cm)</td><td align="center" rowspan="1" colspan="1">166.1 &#x000b1; 7.0 (151&#x02013;180)</td><td align="center" rowspan="1" colspan="1">167.4 &#x000b1; 8.0 (146&#x02013;181)</td><td align="center" rowspan="1" colspan="1">0.452</td><td align="center" rowspan="1" colspan="1">&#x02212;0.375</td><td align="center" rowspan="1" colspan="1">0.114</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Body mass (kg)</td><td align="center" rowspan="1" colspan="1">54.9 &#x000b1; 7.9</td><td align="center" rowspan="1" colspan="1">54.8 &#x000b1; 7.8</td><td align="center" rowspan="1" colspan="1">0.974</td><td align="center" rowspan="1" colspan="1">&#x02212;0.431</td><td align="center" rowspan="1" colspan="1">0.446</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;BMI (kg&#x02219;m<sup>&#x02212;2</sup>)</td><td align="center" rowspan="1" colspan="1">19.8 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">19.5 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">0.413</td><td align="center" rowspan="1" colspan="1">&#x02212;0.256</td><td align="center" rowspan="1" colspan="1">0.623</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Fat-free Mass (kg)</td><td align="center" rowspan="1" colspan="1">48.7 &#x000b1; 7.2</td><td align="center" rowspan="1" colspan="1">47.5 &#x000b1; 7.1</td><td align="center" rowspan="1" colspan="1">0.442</td><td align="center" rowspan="1" colspan="1">&#x02212;0.267</td><td align="center" rowspan="1" colspan="1">0.611</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Percent Fat %</td><td align="center" rowspan="1" colspan="1">11.2 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">13.4 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">0.007*</td><td align="center" rowspan="1" colspan="1">&#x02212;1.075</td><td align="center" rowspan="1" colspan="1">&#x02212;0.177</td></tr><tr><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Performance data</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Training Load (hours per week)</td><td align="center" rowspan="1" colspan="1">15.3 &#x000b1; 6.3 (6&#x02013;33)</td><td align="center" rowspan="1" colspan="1">15.6 &#x000b1; 4.9 (6&#x02013;28)</td><td align="center" rowspan="1" colspan="1">0.984</td><td align="center" rowspan="1" colspan="1">&#x02212;0.172</td><td align="center" rowspan="1" colspan="1">0.323</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;HR<sub>max</sub> (beats&#x02219;min<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">192.0 &#x000b1; 7.0</td><td align="center" rowspan="1" colspan="1">195.0 &#x000b1; 8.0</td><td align="center" rowspan="1" colspan="1">0.022*</td><td align="center" rowspan="1" colspan="1">&#x02212;0.966</td><td align="center" rowspan="1" colspan="1">&#x02212;0.075</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;VO<sub>2max</sub> (mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">62.8 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">58.5 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">0.301</td><td align="center" rowspan="1" colspan="1">1.210</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;VO<sub>2max</sub> (mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>LBM<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">72.2 &#x000b1; 8.7</td><td align="center" rowspan="1" colspan="1">67.9 &#x000b1; 6.0</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">0.131</td><td align="center" rowspan="1" colspan="1">1.027</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;VO<sub>2maxalt</sub> (mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">62.8 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">50.6 &#x000b1; 4.0</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">1.911</td><td align="center" rowspan="1" colspan="1">3.087</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;RQ</td><td align="center" rowspan="1" colspan="1">1.23 &#x000b1; 0.10</td><td align="center" rowspan="1" colspan="1">1.26 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">0.163</td><td align="center" rowspan="1" colspan="1">&#x02212;0.755</td><td align="center" rowspan="1" colspan="1">0.127</td></tr><tr><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Hematological data</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td><td align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Htc (%)</td><td align="center" rowspan="1" colspan="1">47.3 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">44.7 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">0.480</td><td align="center" rowspan="1" colspan="1">1.405</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;[Hb] (g&#x02219;dL<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">16.3 &#x000b1; 1.0</td><td align="center" rowspan="1" colspan="1">15.1 &#x000b1; 1.0</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">0.735</td><td align="center" rowspan="1" colspan="1">1.690</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hbmass (g)</td><td align="center" rowspan="1" colspan="1">792.3 &#x000b1; 152.1</td><td align="center" rowspan="1" colspan="1">742.3 &#x000b1; 162.7</td><td align="center" rowspan="1" colspan="1">0.166</td><td align="center" rowspan="1" colspan="1">&#x02212;0.127</td><td align="center" rowspan="1" colspan="1">0.756</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;EV (mL)</td><td align="center" rowspan="1" colspan="1">2,295.0 &#x000b1; 455.4</td><td align="center" rowspan="1" colspan="1">2,199.0 &#x000b1; 477.9</td><td align="center" rowspan="1" colspan="1">0.361</td><td align="center" rowspan="1" colspan="1">&#x02212;0.234</td><td align="center" rowspan="1" colspan="1">0.644</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;BV (mL)</td><td align="center" rowspan="1" colspan="1">5,315.6 &#x000b1; 907.8</td><td align="center" rowspan="1" colspan="1">5,397.4 &#x000b1; 1,066.6</td><td align="center" rowspan="1" colspan="1">0.713</td><td align="center" rowspan="1" colspan="1">&#x02212;0.521</td><td align="center" rowspan="1" colspan="1">0.356</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PV (mL)</td><td align="center" rowspan="1" colspan="1">3,020.6 &#x000b1; 480.5</td><td align="center" rowspan="1" colspan="1">3,198.4 &#x000b1; 618.4</td><td align="center" rowspan="1" colspan="1">0.115</td><td align="center" rowspan="1" colspan="1">&#x02212;0.761</td><td align="center" rowspan="1" colspan="1">0.121</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hbmass (g&#x02219;kg<sup>&#x02212;1</sup> LBM)</td><td align="center" rowspan="1" colspan="1">16.2 &#x000b1; 1.1</td><td align="center" rowspan="1" colspan="1">15.5 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">0.197</td><td align="center" rowspan="1" colspan="1">&#x02212;0.025</td><td align="center" rowspan="1" colspan="1">0.861</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;EV (mL&#x02219;kg<sup>&#x02212;1</sup> LBM)</td><td align="center" rowspan="1" colspan="1">41.5 &#x000b1; 3.6</td><td align="center" rowspan="1" colspan="1">39.6 &#x000b1; 5.2</td><td align="center" rowspan="1" colspan="1">0.065</td><td align="center" rowspan="1" colspan="1">&#x02212;0.026</td><td align="center" rowspan="1" colspan="1">0.860</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;BV (mL&#x02219;kg<sup>&#x02212;1</sup> LBM)</td><td align="center" rowspan="1" colspan="1">96.5 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">97.6 &#x000b1; 11.7</td><td align="center" rowspan="1" colspan="1">0.609</td><td align="center" rowspan="1" colspan="1">&#x02212;0.553</td><td align="center" rowspan="1" colspan="1">0.324</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PV (mL&#x02219;kg<sup>&#x02212;1</sup> LBM)</td><td align="center" rowspan="1" colspan="1">55.0 &#x000b1; 4.5</td><td align="center" rowspan="1" colspan="1">58.0 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">0.062</td><td align="center" rowspan="1" colspan="1">&#x02212;0.925</td><td align="center" rowspan="1" colspan="1">&#x02212;0.035</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;ARC (10<sup>&#x02013;&#x02212;3</sup> cells&#x02219;&#x003bc;L<sup>&#x02212;1</sup>)</td><td align="center" rowspan="1" colspan="1">65.1 &#x000b1; 20.6</td><td align="center" rowspan="1" colspan="1">48.6 &#x000b1; 11.2</td><td align="center" rowspan="1" colspan="1">0.001*</td><td align="center" rowspan="1" colspan="1">0.522</td><td align="center" rowspan="1" colspan="1">1.452</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Values are presented as mean (SD). Minimum and maximum values. Significance of differences between the groups: *p &#x0003c; 0.05.</p></fn><fn><p>Abbreviations: LBM, lean body mass; BMI, body mass index; TL, training load; HR<sub>max,</sub> maximal heart rate; VO<sub>2max,</sub> maximal oxygen uptake; RQ, respiratory quotient; Htc, hematocrit; Hb, hemoglobin concentration; Hbmass, hemoglobin mass; ARC, absolute reticulocyte count; BV, blood volume; PV, plasma volume; EV, erythrocyte volume. CI: confidence interval.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>3.2 Hematological parameters</title><p>The outcomes from <xref rid="T1" ref-type="table">Table 1</xref> reveal that moderate altitude impacted higher values in nearly all measured hematological parameters related to oxygen transport capacity. Several key hematological parameters exhibited statistical differences. The absolute reticulocyte count was 34% (95% CI: [9.03, 23.81]; p-value = 0.001) higher in altitude natives than lowlanders. Similar differences were observed for hematocrit and hemoglobin concentration (95% CI: [1.36, 3.78]; p = 0.001, 95% CI [0.78, 1.69]; p = 0.001, respectively), all of which showed differences in the altitude natives. However, there were no differences in blood/plasma volumes, hemoglobin mass, and erythrocyte volume between the natives and the lowlanders groups. No statistically significant differences were found between inline skaters, athletic runners, and cyclists in all measured hematological parameters (<xref rid="s13" ref-type="sec">Supplementary Table S1</xref>).</p></sec><sec id="s3-3"><title>3.3 Metabolomics data</title><p>Untargeted metabolomics analysis assessed the changed metabolomic profiles linked with individuals from moderate-altitude regions and those from lowland areas in Colombian endurance-trained adolescents. A multiplatform strategy was employed to detect the maximum number of metabolites displaying alterations. Examination of the clusters in the PCA models revealed the grouping of quality control samples across the utilized analytical platforms (<xref rid="s13" ref-type="sec">Supplementary Figure S1</xref>, shown by orange dots), suggesting analytical stability across all platforms utilized.</p><p>In order to evaluate the potential influence of additional variables on sample clustering, a multivariate PCA approach was also applied to the following variables: type of sport practiced&#x02014;athletics (ATH), cycling (CYC), or inline skating (SKA); biological maturation status according to Tanner stages (III, IV, and V); hematocrit (Htc%) categorized as &#x0003c;45%, 45%&#x02013;48%, and &#x0003e;48%; percent fat (%) categorized as &#x0003c;10%, 10%&#x02013;15%, and &#x0003e;15%; and VO<sub>2</sub>peak (mL&#x02219;min<sup>&#x02212;1</sup>&#x02219;kg<sup>&#x02212;1</sup>) classified as &#x0003c;60, 60&#x02013;65, and &#x0003e;65 (<xref rid="s13" ref-type="sec">Supplementary Figure S2</xref>). However, the exploration of these variables did not reveal any remarkable clustering trends, which may suggest a limited role as confounding variables in this study. Nevertheless, it is recommended that these variables be further explored and analyzed in future investigations. Following verification of the performance of each analytical platform and the limited influence of additional variables on sample clustering, the supervised OPLS-DA was utilized to enhance the differentiation between the groups (<xref rid="F1" ref-type="fig">Figures 1a&#x02013;c</xref>). This method aimed to identify the molecular characteristics significantly contributing to the separation of these groups.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Multivariate models for metabolomic analysis. <bold>(a)</bold> LC-MS(+): <italic>R</italic>
<sup>2</sup>Y: 0.644, <italic>Q</italic>
<sup>2</sup>: 0.659, CV-ANOVA: 1.13<sup>e&#x02212;12</sup>. <bold>(b)</bold> LC-MS(&#x02212;): <italic>R</italic>
<sup>2</sup>Y: 0.669, <italic>Q</italic>
<sup>2</sup>: 0.756, CV-ANOVA: 6.92<sup>e&#x02212;15</sup>. <bold>(c)</bold> GC-MS: <italic>R</italic>
<sup>2</sup>Y: 0.939, <italic>Q</italic>
<sup>2</sup>: 0.614, CV-ANOVA: 1.07<sup>e&#x02212;11</sup>. Dots in red and blue colors denote samples from altitude natives and the lowlanders group, respectively.</p></caption><graphic xlink:href="fmolb-12-1571103-g001" position="float"/></fig><p>The OPLS-DA scoring plot depicted in <xref rid="F1" ref-type="fig">Figures 1a&#x02013;c</xref> clearly showed distinct clustering between the altitude natives (red dots) and lowlanders (blue dots) across all implemented analytical platforms. Additionally, the metrics <italic>R</italic>
<sup>2</sup> and <italic>Q</italic>
<sup>2</sup>, evaluating the model&#x02019;s goodness of fit and predictive ability based on the data, respectively, yielded satisfactory values (<italic>R</italic>
<sup>2</sup>: 0.644&#x02013;0.939; <italic>Q</italic>
<sup>2</sup>: 0.614&#x02013;0.756). To ensure the model&#x02019;s robustness, cross-validation variance (CV-ANOVA) was performed, confirming significant models across all examined platforms (CV-ANOVA &#x0003c;0.05). This observation suggests that the multivariate models avoided overfitting (<xref rid="B21" ref-type="bibr">Eriksson et al., 2008</xref>).</p><p>To identify altered metabolites between altitude natives and lowlanders, a combination method that included both UVA with a significance level (<italic>p-</italic>value) below 0.05 and MVA with a VIP threshold over 1 was used. Employing this approach, 161 altered metabolites were found on all the platforms used during the study (<xref rid="F2" ref-type="fig">Figure 2a</xref>). Of these 161 metabolites, around 74.5% (120 metabolites), corresponded to lipid-like compound classes, while 15.5% (41 metabolites) belonged to non-lipid chemical families. Regarding overall trends, it was noted that around 52.2% (84 metabolites) showed an increase, while 47.8% (77 metabolites) exhibited a decrease among moderate-altitude native athletes.</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Altered metabolites and biosynthetic pathways among altitude natives and lowlander athletes. <bold>(a)</bold> The chemical classes of altered metabolites between altitude natives and lowlander athletes are shown according to the color code. In green, metabolites are downregulated, and in red, they are upregulated in altitude natives. <bold>(b)</bold> Enrichment analysis of altered pathways in comparing altitude natives and lowlander athletes. The significance of pathway alteration is indicated according to the color scale.</p></caption><graphic xlink:href="fmolb-12-1571103-g002" position="float"/></fig><p>The altered lipid metabolites identified in the study belonged to chemical classes such as carnitines (5.59%), fatty acids (12.42%), glycerolipids (1.86%), glycerophospholipids (38.51%), sphingolipids (4.35%), sterol lipids (9.94%), and others (1.86%). Regarding compound types, no uniform trends were observed across the comparisons, except for the family of sterol lipids, which exhibited a downward trend in altitude natives compared to lowlanders (<xref rid="F2" ref-type="fig">Figure 2a</xref>; <xref rid="s13" ref-type="sec">Supplementary Table S2</xref>). On the other hand, the altered non-lipid compounds identified mainly belonged to chemical classes, including amino acids (6.21%), carbohydrates (4.97%), carboxylic acids (1.86%), peptides (4.97%), pyrimidines (3.11%), and others (4.35%). Notably, trends in certain chemical classes stand out, such as carbohydrates, amino acids, peptides, and carboxylic acids, which were predominantly found to be increased in altitude natives compared to lowlanders (<xref rid="F2" ref-type="fig">Figure 2a</xref>; <xref rid="s13" ref-type="sec">Supplementary Table S2</xref>).</p><p>
<xref rid="F2" ref-type="fig">Figure 2b</xref> illustrates the global enrichment analysis, revealing dysregulated metabolic pathways between altitude natives and lowlanders. The comparison uncovered multiple dysregulated pathways (highlighted in shades of red), primarily associated with lipid, carbohydrate, and amino acid metabolism. These pathways include lipid metabolism, such as linolenic and linoleic acid, sphingolipid, and arachidonic acid metabolism, as well as the transfer of acetyl groups into mitochondria and fatty acid biosynthesis. Other implicated pathways were found, such as galactose metabolism, phenylalanine and tyrosine metabolism, pyrimidine metabolism, the TCA cycle, and gluconeogenesis. Interestingly, a significant portion of these pathways are related to energy production.</p><p>Given the large number of altered metabolites and aiming to establish more detailed trends among the altered metabolites in the study groups, the set of altered metabolites with the most significant changes (fold change &#x0003c;0.6; &#x0003e;1.4) between the two groups was analyzed using heat maps that allow the visualization of metabolite patterns changing between the groups. Thus, green colors indicate decreased metabolite levels, and red colors indicate increased metabolites (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Heatmap of metabolites with statistically significant variation between altitude natives and lowlander athletes. The rows correspond to each altered metabolite identified, the columns correspond to the analyzed samples divided into clades: Altitude natives (red) and lowlanders (blue). The level of variation is indicated on the right side on a color intensity scale representing relative abundance, where red colors denote metabolite increase and green colors denote metabolite decrease.</p></caption><graphic xlink:href="fmolb-12-1571103-g003" position="float"/></fig><p>Interestingly, the heatmap depicted in <xref rid="F3" ref-type="fig">Figure 3</xref> highlights the robust clustering of samples from the two groups (top clades), suggesting that the metabolites used for its construction enable a clear classification of samples belonging to altitude native (samples in red) and lowlanders (samples in blue) athletes. Regarding the clustering of altered metabolites, three major clades are observed on the left side. The upper clade, comprising metabolites from indole carbinol to glucose, consists of heterogeneous metabolites, including carbohydrates, sphingolipids, carboxylic acid derivatives, and some fatty acids. This clade does not exhibit a prominent trend. However, these metabolites appear to be increased in altitude natives compared to lowlanders. The intermediate clade ranges from LPI 18:1 to OA-PC, consisting predominantly of glycerophospholipids and some fatty acids such as leukotrienes and eicosanoids (important inflammatory mediators), with the lysophospholipids being the most representative. This clade was characterized by being increased in altitude natives compared to lowlanders. Finally, the lower clade encompasses metabolites from dihydroxycholesterol to hydroxybutyric acid. This heterogeneous clade is primarily constituted by some amino acids and peptides, carnitines, other lysophospholipids, and sterol lipids, with the latter class being the most representative. Interestingly, metabolites in this clade exhibited downward trends in altitude natives compared to lowlanders. In summary, two trends can describe most changes found in the clades: lysophospholipids are predominantly increased in altitude natives, while sterol lipids are decreased.</p><p>Finally, certain glycerophospholipids showed a high and significant correlation with VO<sub>2max</sub> data (<xref rid="s13" ref-type="sec">Supplementary Figure S3</xref>). Furthermore, using Spearman correlation, we identified other metabolites that also correlated with VO<sub>2max</sub> and hematology data. In <xref rid="s13" ref-type="sec">Supplementary Figure S3</xref>, we highlighted all the metabolites that significantly correlated with the physiological and hematological data (Spearman correlation, p-value &#x0003c;0.05, <italic>r</italic> &#x0003e; 0.4 or <italic>r</italic> &#x0003c; &#x02212;0.4). Besides glycerophospholipids, several other compounds also appear to be highly correlated with VO<sub>2max</sub> and hematology data.</p></sec><sec id="s3-4"><title>3.4 Potential biomarkers of altitude exposure</title><p>Considering their highest levels of identification (ID level 2), fold change, VIP values, and p-values with FDR, a total of eight metabolites (glycerol, aminobenzoic acid, acetyl-mannosamine, oxo-proline, isopropyl thiogalactopyranoside, tyrosine, glucose, LPC17:0) were chosen as potential indicators of altitude exposure in athletes. The predictive performance of each selected biomarker, assessed through ROC analysis, is illustrated in <xref rid="F4" ref-type="fig">Figure 4</xref>. Notably, the findings revealed that glycerol demonstrated the most significant performance, achieving an area under the curve (AUC) value of 0.799 (CI: 0.692&#x02013;0.89), accompanied by sensitivities and specificities of 0.8 and 0.7, respectively. The remaining seven compounds also exhibit good discriminatory capabilities, with AUC values exceeding 0.75 and sensitivities and specificities greater than 0.6.</p><fig position="float" id="F4"><label>FIGURE 4</label><caption><p>Analysis of the Receiver Operating Characteristics of potential plasma biomarkers for altitude exposure. ROC curve analysis and box plot of metabolites with the highest contribution of separating the studied groups. Boxplot in red and blue colors, representing altitude native and lowlanders athletes, respectively. Data were shown by the median, with the range from minimum to maximum.</p></caption><graphic xlink:href="fmolb-12-1571103-g004" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>4 Discussion</title><p>This research compared the plasma metabolic profiles of adolescents who live and train at moderate altitudes and their counterparts residing at lower altitudes. An untargeted metabolomics approach was employed to identify metabolic profiles and biomarkers associated with chronic adaptation to hypobaric hypoxia. The supervised model analyses discerned distinct metabolic patterns in the two groups, suggesting that chronic residence at moderate altitude is associated with specific metabolic profiles in adolescent endurance athletes. The altered metabolites belong to several classes and include key metabolic pathways related to lipids, including the metabolism of sphingolipids and fatty acids like arachidonic, linolenic, and linoleic acid, fatty acid oxidation, and fatty acid biosynthesis. A variety of processes associated with the TCA cycle, glycolysis, and amino acids are also implicated (<xref rid="F5" ref-type="fig">Figure 5</xref>).</p><fig position="float" id="F5"><label>FIGURE 5</label><caption><p>Global metabolic changes in response to hypoxia in adolescent athletes. The metabolites represented in red, green, and purple correspond to increased, decreased, and no trend, respectively.</p></caption><graphic xlink:href="fmolb-12-1571103-g005" position="float"/></fig><p>Despite existing studies exploring metabolic shifts during hypoxic exposure in adults at moderate altitudes, the underlying molecular mechanisms in trained adolescents remain relatively unexplored, and the metabolomic nuances of chronic adaptation remain elusive. Recently, <xref rid="B28" ref-type="bibr">Gao et al. (2023)</xref> employed metabolomic analysis to study systemic changes resulting from acute hypoxia and found that adenosine, guanosine, inosine, xanthurenic acid, 5-oxo-ETE, raffinose, indole-3-acetic acid and biotin were highly upregulated after exposure at an altitude of 3650 m. <xref rid="B45" ref-type="bibr">Lawler et al. (2019)</xref> significant alterations in amino acid metabolism, glycolysis, and purine metabolism, and the time course of these changes is different over 14 days of normobaric, simulated altitude (3,000 m) on the metabolic profile of 10 highly trained middle-distance runners. <xref rid="B48" ref-type="bibr">Liao et al. (2016)</xref>, analyzed plasma metabolites and revealed significant disruptions in key metabolic pathways at an altitude of 5300 m. These perturbed pathways encompass inflammatory response-related metabolism, energy metabolism, bile acid metabolism, and heme metabolism. According to <xref rid="B17" ref-type="bibr">D&#x02019;Alessandro et al. (2016)</xref>, the metabolomic analysis of red blood cells revealed correlations between changes in metabolic and physiological pathways as well as athletic performance parameters following exposure to high altitude (5260 m). The comprehensive metabolomic analysis of muscle biopsies indicated improvements in muscle bioenergetics under physiological hypoxia, showcasing changes in glycolytic intermediates, amino acids, and fatty acids (<xref rid="B10" ref-type="bibr">Chicco et al., 2018</xref>). <xref rid="B68" ref-type="bibr">O&#x02019;Brien et al. (2019)</xref> investigated the metabolomic response to progressive exposure to environmental hypoxia in the plasma of 198 healthy individuals before and during an ascent to Everest Base Camp. The study revealed a decrease in isoleucine levels with ascent, along with increasing lactate and decreasing glucose levels, indicating a potential increase in glycolytic rate. All of the findings above highlight the need for a deeper dive into the metabolic mechanisms associated with chronic adaptation to hypobaric hypoxia in adolescents.</p><p>In hypoxic high-altitude conditions, the body&#x02019;s metabolism naturally adjusts to achieve a new dynamic equilibrium. This adaptation results in a metabolic state that differs significantly from that at sea level, reflected in the altered content of various metabolites (<xref rid="B60" ref-type="bibr">Murray, 2009</xref>). Metabolism is crucial for bodily function; it maintains metabolic levels within a normal range and is essential for the body&#x02019;s resistance to the hypoxic conditions of high-moderate altitudes (<xref rid="B9" ref-type="bibr">Chang et al., 2019</xref>). In this study, the metabolites analyzed in basal condition could reflect the resting physiological state of adolescent athletes, influenced by their chronic altitude and endurance adaptation. Interestingly, the glycerophospholipids played a crucial role in distinguishing between the groups, with significantly elevated concentrations of certain Lysophosphatidylcholines (LPC) observed in altitude natives (<xref rid="s13" ref-type="sec">Supplementary Table S2</xref>). LPC is primarily generated within cells through the action of phospholipase A2, an enzyme that removes one of the fatty acid groups from phosphatidylcholine (PC) to yield LPC (<xref rid="B45" ref-type="bibr">Law et al., 2019</xref>). LPC mediates various cell-signaling pathways within monocytes/macrophages and specific receptors, actively contributing to the inflammatory response (<xref rid="B19" ref-type="bibr">Duong et al., 2004</xref>; <xref rid="B38" ref-type="bibr">Kabarowski, 2009</xref>; <xref rid="B69" ref-type="bibr">Oestvang and Johansen, 2006</xref>). Consistent with our findings, lipidomic studies have shown a notable increase in LPC levels in response to hypoxic exposure. Furthermore, insights from lipid consumption research propose that LPC serves as a more easily accessible nutrient source, supporting cellular proliferation in hypoxic environments (<xref rid="B103" ref-type="bibr">Yu et al., 2014</xref>; <xref rid="B39" ref-type="bibr">Kamphorst et al., 2013</xref>). On the other hand, several free fatty acids (FFA), including linoleic acid, arachidonic acid, and eicosapentaenoic acid, were lower among altitude natives. Our findings suggest a shift in linoleic acid metabolism, indicating a reconfigured utilization of linoleic acid and arachidonic acid to produce prostaglandins and leukotrienes as molecular byproducts (<xref rid="s13" ref-type="sec">Supplementary Table S2</xref>). In our data, leukotriene B4 and prostaglandin F2 were elevated in the altitude natives group. This could be related to the decrease in arachidonic acid metabolism. Linoleic acid serves as a precursor to arachidonic acid through processes of elongation and unsaturation. <xref rid="B2" ref-type="bibr">Balsinde et al. 2002</xref>) have demonstrated that arachidonic acid can undergo metabolism by cyclooxygenases and lipooxygenases, resulting in the formation of various eicosanoids like prostaglandins, thromboxanes, leukotrienes, and lipoxins, all of which play roles in the inflammatory response. We observed an increase in oxo-ETE, a product of arachidonic metabolism, in the altitude natives group (<xref rid="s13" ref-type="sec">Supplementary Table S2</xref>). <xref rid="B28" ref-type="bibr">Gao et al. (2023)</xref> have indicated that exposure to hypoxia leads to elevated levels of 5-oxo-ETE in healthy volunteers from lowland regions. This compound acts synergistically with various lipid and peptide mediators, playing a role in regulating inflammation alongside other lipid mediators, chemokines, and cytokines (<xref rid="B22" ref-type="bibr">Erlemann et al., 2007</xref>; <xref rid="B29" ref-type="bibr">Grant et al., 2009</xref>; <xref rid="B23" ref-type="bibr">Erlemann et al., 2004</xref>).</p><p>Acetylcarnitines play crucial roles in various cellular energy metabolism pathways and are known to be involved in cellular responses to hypoxia-induced stress (<xref rid="B18" ref-type="bibr">Dambrova et al., 2022</xref>; <xref rid="B48" ref-type="bibr">Liao et al., 2016</xref>; <xref rid="B28" ref-type="bibr">Gao et al., 2023</xref>). Previous studies have shown that acute hypoxia inhibits free fatty acid oxidation, leading to the accumulation of long-chain acylcarnitines (<xref rid="B48" ref-type="bibr">Liao et al., 2016</xref>; <xref rid="B5" ref-type="bibr">Bruder and Raff, 2010</xref>). Higher urinary acetylcarnitine excretion has been observed in individuals susceptible to acute mountain sickness (<xref rid="B86" ref-type="bibr">Sibomana et al., 2021</xref>). <xref rid="B28" ref-type="bibr">Gao et al. (2023)</xref> reported an increase in acylcarnitines during hypoxia exposure, which then decreased upon return to low altitude. In contrast, <xref rid="B33" ref-type="bibr">Horscroft et al. (2017)</xref> reported lower levels of acylcarnitines in altitude natives compared to lowlanders pre-exposure to high altitude, and these levels remained low during hypoxia exposure. The current study observed a decrease in medium and long-chain acylcarnitine levels in the altitude natives (<xref rid="s13" ref-type="sec">Supplementary Table S2</xref>). We suggest that the carnitine system is essential for moderate altitude adaptation, possibly contributing to elite athletes&#x02019; improved endurance performance. The altered behavior of acylcarnitines during altitude exposure reveals multiple nuances that are not yet fully understood. An alternative role for acylcarnitines in the context of high-altitude hypoxia pertains to their role in fueling the Lands cycle, a process of lipid damage repair that involves the enzymes lysophosphatidylcholine acyl-transferase (e.g., LPCAT3) to recyclates lysophospholipids upon phospholipase activation under hypoxic conditions (<xref rid="B98" ref-type="bibr">Wu et al., 2016</xref>; <xref rid="B64" ref-type="bibr">Nemkov et al., 2024</xref>; <xref rid="B100" ref-type="bibr">Xu et al., 2022</xref>).</p><p>Sphingosine 1-phosphate (S1P) is a lipid mediator produced through the metabolism of sphingomyelin. S1P is produced through two enzymes&#x02014;sphingosine kinase 1 (Sphk1) and sphingosine kinase 2 (Sphk2). Previous research has highlighted that extracellular S1P plays a role in various physiological activities, such as immune cell trafficking, hematopoietic stem cell trafficking, vascular integrity, and cell proliferation, achieved by activating its five G-protein-coupled receptors (<xref rid="B58" ref-type="bibr">Mendelson et al., 2014</xref>) and also plays a role in protecting the heart against ischemia/reperfusion injury by promoting lymphocyte egress and inhibiting apoptosis. (<xref rid="B40" ref-type="bibr">Karliner, 2013</xref>). <xref rid="B89" ref-type="bibr">Sun et al. (2016)</xref>, showed that Sphk1 activity and S1P levels are induced in mature erythrocytes of lowland volunteers exposed to an altitude of 5,260 m. In the same study, using a mouse model, these authors demonstrated that increased Sphk1 activity in red blood cells (RBCs) contributes to elevated S1P production within RBCs in hypoxic conditions. Similar findings have been reported in the context of <italic>ex vivo</italic> exposure of human or murine RBCs to hypoxia, e.g., in the context of hypoxic storage under blood bank conditions, whereby S1P-dependent promotion of glycolysis came at the expense of the antioxidant potential <italic>via</italic> depression of the NADPH-generating pentose phosphate pathway (<xref rid="B30" ref-type="bibr">Hay et al., 2023</xref>). Other authors have reported that (S1P) is involved in the induction of cyclooxygenase-2 (COX-2) and regulates the production of eicosanoids (<xref rid="B101" ref-type="bibr">Yang et al., 2020</xref>). Hodun et al. (<xref rid="B31" ref-type="bibr">Hodun et al., 2021</xref>), demonstrated that the activation of the inflammatory response plays a role in the reduced S1P levels during prolonged ultra-endurance competition. Interestingly, our results showed low levels of S1P and eicosanoids in the altitude natives, which could play a central role in the responses to intense endurance training (inflammatory reaction) in moderate altitude environments.</p><p>Bile acids play an important role in various physiological functions, such as facilitating the absorption of nutrients in the intestines and the secretion of lipids, toxic metabolites, and xenobiotics in bile. Taurochenodeoxycholic acid (TCDCA), a major bile acid, is synthesized by combining taurine and chenodeoxycholic acid (CDCA) in organisms. In our own study, the bile acids TCDCA and CDCA were downregulated in the altitude natives. Previous studies showed the bile acids TCDCA and glycochenodeoxycholate-3-sulfate increased after high altitude exposure (<xref rid="B48" ref-type="bibr">Liao et al., 2016</xref>). Additional studies have demonstrated that acute hypobaric hypoxia can lead to substantial damage to the liver and gastrointestinal mucosa (<xref rid="B77" ref-type="bibr">Rong et al., 2009</xref>). A recently identified membrane receptor, G&#x003b1;s protein-coupled receptor (TGR5), responds to bile acid activation (<xref rid="B41" ref-type="bibr">Kawamata et al., 2003</xref>). TGR5 is expressed in various tissues, including the gallbladder, spleen, liver, intestine, kidney, skeletal muscle, pancreas, adipocytes, and macrophages. TGR5/cAMP signaling demonstrates anti-inflammatory functions in the liver and intestine by inhibiting nuclear factor NF-&#x003ba;B-mediated inflammatory cytokine production (<xref rid="B96" ref-type="bibr">Wang et al., 2011</xref>; <xref rid="B20" ref-type="bibr">El Kasmi et al., 2018</xref>). Given that high hypoxic exposure induces pro-inflammatory stimuli with subsequent anti-inflammatory responses, this may elucidate the observed downregulation of TCDCA in the altitude natives group.</p><p>The altitude natives exhibited elevated levels of the aromatic amino acid tyrosine. These alterations in amino acid levels suggest metabolic adaptations to fulfill increased energy demands. The decreased ATP production resulting from TCA cycle inhibition triggered by hypobaric hypoxia may prompt the utilization of BCAAs to compensate for energy deficits (<xref rid="B48" ref-type="bibr">Liao et al., 2016</xref>). The elevated levels of tyrosine could be attributed to the replenishment of energy reserves necessary to cope with hypoxic stress. Moreover, tyrosine might aid in regulating oxidative stress, immune response, and inflammation, thus providing protection against tissue damage (<xref rid="B10" ref-type="bibr">Chicco et al., 2018</xref>; <xref rid="B51" ref-type="bibr">Liu et al., 2017</xref>; <xref rid="B49" ref-type="bibr">Shukitt-Hale et al., 1996</xref>; <xref rid="B27" ref-type="bibr">Gandhi et al., 2022</xref>). The altitude natives also exhibited elevated levels of alanine, a crucial gluconeogenic &#x003b1;-amino acid responsible for delivering carbon derived from amino acid breakdown in peripheral tissues and skeletal muscles. Alanine, a component of all proteins and peptides, serves as a source of energy through the oxidation of pyruvate released by the transamination of alanine. It undergoes conversion into biomolecules like pyruvate, 2-oxoglutarate, and fumarate, which enter the TCA cycle to address ATP depletion and energy requirements, thereby facilitating acclimatization to high altitudes (<xref rid="B27" ref-type="bibr">Gandhi et al., 2022</xref>; <xref rid="B54" ref-type="bibr">MA and Ma, 2017</xref>, <xref rid="B17" ref-type="bibr">D&#x02019;Alessandro et al., 2016</xref>). On the other hand, isoleucine, a branched-chain amino acid (BCAA), serves as a primary mediator of alanine and glutamine. Our data demonstrated that individuals native to moderate altitude exhibited lower levels of isoleucine than lowlanders. The catabolism of BCAAs initiates in skeletal muscle with the transamination of &#x003b1;-ketoglutarate, producing branched-chain ketoacids, which are further oxidized as succinyl Co-A in the TCA cycle. Additionally, BCAAs play a crucial role in energy metabolism, and their increase indicates impaired energy metabolism due to oxidative stress and compromised mitochondrial respiration (<xref rid="B68" ref-type="bibr">O&#x02019;Brien et al., 2019</xref>; <xref rid="B53" ref-type="bibr">Luo et al., 2012</xref>; <xref rid="B72" ref-type="bibr">Pichler Hefti et al., 2013</xref>). <xref rid="B68" ref-type="bibr">O&#x02019;Brien et al. (2019)</xref> recently demonstrated that isoleucine decreased in response to progressive exposure to environmental hypoxia in the plasma of healthy individuals. Carboxylic acid metabolism is responsive to hypoxia in mitochondria-endowed cells, whereby electron transport chain uncoupling following limited oxygen availability (e.g., ischemic (<xref rid="B11" ref-type="bibr">Chouchani et al., 2014</xref>) or hemorrhagic hypoxia (<xref rid="B16" ref-type="bibr">D&#x02019;Alessandro et al., 2017</xref>), but also exercise (<xref rid="B76" ref-type="bibr">Reddy et al., 2020</xref>)) coincides with elevation of succinate and other dicarboxylates that contribute to the stabilization of HIF1&#x003b1; and&#x02013;along with the stimulation of erythropoiesis&#x02013;contribute to inflammatory cascades such as the expression of HIF-targets like interleukin 1 beta (<xref rid="B91" ref-type="bibr">Tannahill et al., 2013</xref>). In mitochondria-devoid cells, like RBCs, hypoxic metabolic reprogramming also activates non-canonical carboxylate metabolism <italic>via</italic> cytosolic isoforms of TCA cycle enzymes (e.g., IDH1, MDH1, ME1), which contribute to the homeostasis of reducing equivalents through orthogonal pathways than glycolysis and the hexose monophosphate shunt (<xref rid="B66" ref-type="bibr">Nemkov et al., 2017</xref>).</p><p>In this research, unsupervised biomarker analyses identified relevant metabolites that could indicate chronic adaptation to moderate altitude and cardiorespiratory fitness. These metabolites include glycerol and 5-oxoproline. <xref rid="B3" ref-type="bibr">Benso et al. (2007)</xref> showed that hypoxia at altitude can stimulate lipolysis, increasing blood glycerol levels. Other authors have suggested that plasma glycerol measured at rest and after physical activity could potentially serve as a biomarker of cardiorespiratory fitness (<xref rid="B47" ref-type="bibr">Lewis et al., 2010</xref>). In our study, the altitude natives group showed less oxo-proline concentrations than lowlanders individuals. Oxoproline, also known as 5-oxoproline or pyroglutamate, is an intermediate in the glutathione metabolism pathway and can accumulate when there is a deficiency in glutathione synthetase (<xref rid="B52" ref-type="bibr">Lu, 2013</xref>). In oxoprolinase-deficient mature RBCs, which contribute significantly to the circulating levels of this metabolite, 5-oxoproline is an end product of the gamma-glutamyl cycle (<xref rid="B70" ref-type="bibr">Paglia et al., 2016</xref>). Elevated levels of oxoproline are associated with oxidative stress and can serve as a biomarker to assess the redox state of cells and tissues in clinical settings (<xref rid="B85" ref-type="bibr">Sharma et al., 2022</xref>). Several studies highlight the role of oxoproline in oxidative stress. One study notes that 5-oxoproline can induce protein oxidation in tissues, marking it a significant oxidative stress indicator. The same study observed that Oplah full-body knock-out mice with elevated oxoproline levels showed increased oxidative stress, cardiac fibrosis, and other symptoms related to heart failure (<xref rid="B94" ref-type="bibr">van der Pol et al., 2018</xref>).</p><p>Additionally, correlative analyses indicated a linkage between certain glycerophospholipids and VO<sub>2max</sub> H&#x000f8;eg, <xref rid="B32" ref-type="bibr">H&#x000f8;eg et al. (2020)</xref> conducted non-targeted and targeted metabolomic testing on ultramarathon runners&#x02019; plasma samples. They found that higher levels of specific phosphatidylcholines were associated with faster finish times in the Western States Endurance Run. This supports the idea that certain glycerophospholipids, like phosphatidylcholine, may be linked to superior aerobic performance and higher VO<sub>2max</sub> levels. These findings are also consistent with those of <xref rid="B7" ref-type="bibr">Bye et al. (2012)</xref>, who found that individuals with higher VO<sub>2max</sub> had lower levels of free choline and higher levels of phosphatidylcholine. This suggests that choline metabolism might be linked to cardiorespiratory fitness, with potential implications for cardiovascular health&#x0200b; and type 2 diabetes (<xref rid="B67" ref-type="bibr">Newsom et al., 2016</xref>; <xref rid="B95" ref-type="bibr">Wallner and Schmitz, 2011</xref>; <xref rid="B25" ref-type="bibr">Floegel et al., 2013</xref>).</p><p>The present study compared the plasma metabolic profiles of athletes trained at moderate and low altitudes to identify the potential metabolic pathways underlying these differences.</p><p>The plasma metabolite screening was focused on adolescents trained in endurance sports. Additional studies with larger cohorts are needed, including other populations, such as sedentary adolescents, to fully elucidate the metabolic response to chronic adaptation to moderate altitude. While the current research has provided a comprehensive view of chronic adaptation to altitude and cardiovascular endurance exercise, future studies may consider applying more targeted approaches based on these results to potentially identify metabolites that enhance altitude adaptation processes. Likewise, the study focuses on chronic adaptation but does not account for the possible differences between short-term and long-term metabolic responses to altitude training. Obviously, controlling additional variables such as nutritional intake, sport-specific demands, and training season phase could improve even more future investigations. Moreover, although pre-analytical factors&#x02014;such as fasting state and sampling time&#x02014;were controlled, the inclusion of a longitudinal component in future studies would help disentangle the effects of circadian, seasonal, and training-related variation on the metabolome.</p></sec><sec sec-type="conclusion" id="s5"><title>5 Conclusion</title><p>This metabolomic study represents a pioneering exploration of aspects associated with chronic adaptation to moderate altitudes. Using a combined LC-QTOF-MS and GC-QTOF-MS approach, we identified target metabolites that span a wide range of metabolic pathways, shedding light on inflammatory response-related metabolism (such as linoleic acid, arachidonic acid, and phospholipid metabolism), energy metabolism (including glycolysis and fatty acid metabolism), as well as bile acid and sphingolipid metabolism. The metabolites identified in these analyses have the potential to serve as valuable biomarkers for further research into cardiorespiratory fitness and adaptation to moderate altitude in adolescents. This approach provides important insights into the metabolic processes underlying the body&#x02019;s response to altitude stress and physical training, helping to identify strategies to improve performance and health in these challenging conditions.</p></sec></body><back><ack><p>We are grateful to the Metabolomics Core Facility, Universidad de los Andes, Bogot&#x000e1;, Colombia for providing high-quality infrastructure for the LC&#x02013;MS and GC-MS analyses and the athletic association team, study participants, parents and coaches for their cooperation.</p></ack><sec sec-type="data-availability" id="s6"><title>Data availability statement</title><p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref rid="s13" ref-type="sec">Supplementary Material</xref>.</p></sec><sec sec-type="ethics-statement" id="s7"><title>Ethics statement</title><p>The studies involving humans were approved by Ethics committee of the National University of Colombia at Bogot&#x000e1; (reference: ID 06/2015). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x02019; legal guardians/next of kin.</p></sec><sec sec-type="author-contributions" id="s8"><title>Author contributions</title><p>CS: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. DP-R: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. EM-M: Conceptualization, Methodology, Resources, Writing &#x02013; review and editing. LL: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Writing &#x02013; review and editing. DP: Formal Analysis, Investigation, Writing &#x02013; review and editing. AD: Data curation, Formal Analysis, Investigation, Writing &#x02013; review and editing. CS: Conceptualization, Data curation, Formal Analysis, Investigation, Writing &#x02013; original draft, Writing &#x02013; review and editing. EC: Conceptualization, Formal Analysis, Methodology, Writing &#x02013; review and editing. GM: Conceptualization, Data curation, Formal Analysis, Writing &#x02013; review and editing. DR-C: Conceptualization, Methodology, Writing &#x02013; review and editing. MC: Conceptualization, Data curation, Formal Analysis, Investigation, Project administration, Resources, Supervision, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. FP: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Supervision, Writing &#x02013; original draft, Writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s11"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s12"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec id="s13"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2025.1571103/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmolb.2025.1571103/full#supplementary-material</ext-link>
</p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Supplementaryfile1.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bahensk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Bunc</surname><given-names>V.</given-names></name><name><surname>Tlust&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Grosicki</surname><given-names>G. J.</given-names></name></person-group> (<year>2020</year>). <article-title>Effect of an eleven-day altitude training program on aerobic and anaerobic performance in adolescent runners</article-title>. <source>Medicina</source>
<volume>56</volume>, <fpage>184</fpage>. <pub-id pub-id-type="doi">10.3390/medicina56040184</pub-id>
<pub-id pub-id-type="pmid">32316168</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J.</given-names></name><name><surname>Winstead</surname><given-names>M. V.</given-names></name><name><surname>Dennis</surname><given-names>E. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Phospholipase A2 regulation of arachidonic acid mobilization</article-title>. <source>FEBS Lett.</source>
<volume>531</volume>, <fpage>2</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(02)03413-0</pub-id>
<pub-id pub-id-type="pmid">12401193</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benso</surname><given-names>A.</given-names></name><name><surname>Broglio</surname><given-names>F.</given-names></name><name><surname>Aimaretti</surname><given-names>G.</given-names></name><name><surname>Lucatello</surname><given-names>B.</given-names></name><name><surname>Lanfranco</surname><given-names>F.</given-names></name><name><surname>Ghigo</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Endocrine and metabolic responses to extreme altitude and physical exercise in climbers</article-title>. <source>Eur. J. Endocrinol.</source>
<volume>157</volume>, <fpage>733</fpage>&#x02013;<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-07-0355</pub-id>
<pub-id pub-id-type="pmid">18057380</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bla&#x0017e;enovi&#x00107;</surname><given-names>I.</given-names></name><name><surname>Kind</surname><given-names>T.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Fiehn</surname><given-names>O.</given-names></name></person-group> (<year>2018</year>). <article-title>Software tools and approaches for compound identification of LC-MS/MS data in metabolomics</article-title>. <source>Metabolites</source>
<volume>8</volume>, <fpage>31</fpage>. <pub-id pub-id-type="doi">10.3390/metabo8020031</pub-id>
<pub-id pub-id-type="pmid">29748461</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bruder</surname><given-names>E. D.</given-names></name><name><surname>Raff</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal and young adult rats</article-title>. <source>Lipids health Dis.</source>
<volume>9</volume>, <fpage>3</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1186/1476-511X-9-3</pub-id>
<pub-id pub-id-type="pmid">20070908</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burtscher</surname><given-names>M.</given-names></name><name><surname>Millet</surname><given-names>G. P.</given-names></name><name><surname>Burtscher</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Hypoxia conditioning for high-altitude pre-acclimatization</article-title>. <source>J. Sci. Sport Exerc.</source>
<volume>4</volume>, <fpage>331</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1007/s42978-021-00150-0</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bye</surname><given-names>A.</given-names></name><name><surname>Vettukattil</surname><given-names>R.</given-names></name><name><surname>Aspenes</surname><given-names>S. T.</given-names></name><name><surname>Giske&#x000f8;deg&#x000e5;rd</surname><given-names>G. F.</given-names></name><name><surname>Gribbestad</surname><given-names>I. S.</given-names></name><name><surname>Wisl&#x000f8;ff</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study</article-title>. <source>PLoS One</source>
<volume>7</volume>, <fpage>e42330</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0042330</pub-id>
<pub-id pub-id-type="pmid">22860113</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>G.</given-names></name><name><surname>Radcenco</surname><given-names>A. L.</given-names></name><name><surname>Evaristo</surname><given-names>J.</given-names></name><name><surname>Monnerat</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics</article-title>. <source>Horm. Mol. Biol. Clin. Investig.</source>
<volume>38</volume>, <fpage>20180045</fpage>, <pub-id pub-id-type="doi">10.1515/hmbci-2018-0045</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xia</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Metabonomics window into plateau hypoxia</article-title>. <source>J. Int. Med. Res.</source>
<volume>47</volume>, <fpage>5441</fpage>&#x02013;<lpage>5452</lpage>. <pub-id pub-id-type="doi">10.1177/0300060519879323</pub-id>
<pub-id pub-id-type="pmid">31594434</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chicco</surname><given-names>A. J.</given-names></name><name><surname>LE</surname><given-names>C. H.</given-names></name><name><surname>Gnaiger</surname><given-names>E.</given-names></name><name><surname>Dreyer</surname><given-names>H. C.</given-names></name><name><surname>Muyskens</surname><given-names>J. B.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: lessons from AltitudeOmics</article-title>. <source>J. Biol. Chem.</source>
<volume>293</volume>, <fpage>6659</fpage>&#x02013;<lpage>6671</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA117.000470</pub-id>
<pub-id pub-id-type="pmid">29540485</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chouchani</surname><given-names>E. T.</given-names></name><name><surname>Pell</surname><given-names>V. R.</given-names></name><name><surname>Gaude</surname><given-names>E.</given-names></name><name><surname>Aksentijevi&#x00107;</surname><given-names>D.</given-names></name><name><surname>Sundier</surname><given-names>S. Y.</given-names></name><name><surname>Robb</surname><given-names>E. L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS</article-title>. <source>Nature</source>
<volume>515</volume>, <fpage>431</fpage>&#x02013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1038/nature13909</pub-id>
<pub-id pub-id-type="pmid">25383517</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Christoulas</surname><given-names>K.</given-names></name><name><surname>Karamouzis</surname><given-names>M.</given-names></name><name><surname>Mandroukas</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Living high-training &#x0201c;low&#x0201d; vs. &#x0201c;living high-training high&#x0201d;: erythropoietic responses and performance of adolescent cross-country skiers</article-title>. <source>J. Sports Med. Phys. Fit.</source>
<volume>51</volume>, <fpage>74</fpage>&#x02013;<lpage>81</lpage>.</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <source>Statistical power analysis for the behavioral sciences</source>. <publisher-loc>New York, United States</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cole</surname><given-names>M. A.</given-names></name><name><surname>Abd Jamil</surname><given-names>A. H.</given-names></name><name><surname>Heather</surname><given-names>L. C.</given-names></name><name><surname>Murray</surname><given-names>A. J.</given-names></name><name><surname>Sutton</surname><given-names>E. R.</given-names></name><name><surname>Slingo</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>On the pivotal role of PPAR&#x003b1; in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury</article-title>. <source>FASEB J.</source>
<volume>30</volume>, <fpage>2684</fpage>&#x02013;<lpage>2697</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201500094R</pub-id>
<pub-id pub-id-type="pmid">27103577</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Earley</surname><given-names>E. J.</given-names></name><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Stephenson</surname><given-names>D.</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M.</given-names></name><name><surname>Hansen</surname><given-names>K. C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Genetic polymorphisms and expression of Rhesus blood group RHCE are associated with 2,3-bisphosphoglycerate in humans at high altitude</article-title>, <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>121</volume>, <fpage>e2315930120</fpage>, <pub-id pub-id-type="doi">10.1073/pnas.2315930120</pub-id>
<pub-id pub-id-type="pmid">38147558</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Moore</surname><given-names>H. B.</given-names></name><name><surname>Moore</surname><given-names>E. E.</given-names></name><name><surname>Reisz</surname><given-names>J. A.</given-names></name><name><surname>Wither</surname><given-names>M. J.</given-names></name><name><surname>Ghasasbyan</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Plasma succinate is a predictor of mortality in critically injured patients</article-title>. <source>J. Trauma Acute Care Surg.</source>
<volume>83</volume>, <fpage>491</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0000000000001565</pub-id>
<pub-id pub-id-type="pmid">28590356</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><name><surname>Monte</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>AltitudeOmics: red blood cell metabolic adaptation to high altitude hypoxia</article-title>. <source>J. Proteome Res.</source>
<volume>15</volume>, <fpage>3883</fpage>&#x02013;<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00733</pub-id>
<pub-id pub-id-type="pmid">27646145</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dambrova</surname><given-names>M.</given-names></name><name><surname>Makrecka-Kuka</surname><given-names>M.</given-names></name><name><surname>Kuka</surname><given-names>J.</given-names></name><name><surname>Vilskersts</surname><given-names>R.</given-names></name><name><surname>Nordberg</surname><given-names>D.</given-names></name><name><surname>Attwood</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials</article-title>. <source>Pharmacol. Rev.</source>
<volume>74</volume>, <fpage>506</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1124/pharmrev.121.000408</pub-id>
<pub-id pub-id-type="pmid">35710135</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duong</surname><given-names>C. Q.</given-names></name><name><surname>Bared</surname><given-names>S. M.</given-names></name><name><surname>Abu-Khader</surname><given-names>A.</given-names></name><name><surname>Buechler</surname><given-names>C.</given-names></name><name><surname>Schmitz</surname><given-names>A.</given-names></name><name><surname>Schmitz</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages</article-title>. <source>Biochim. Biophys. Acta (BBA)-Molecular Cell Biol. Lipids</source>
<volume>1682</volume>, <fpage>112</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2004.03.002</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>EL Kasmi</surname><given-names>K. C.</given-names></name><name><surname>Vue</surname><given-names>P. M.</given-names></name><name><surname>Anderson</surname><given-names>A. L.</given-names></name><name><surname>Devereaux</surname><given-names>M. W.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Balasubramaniyan</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Macrophage-derived IL-1&#x003b2;/NF-&#x003ba;B signaling mediates parenteral nutrition-associated cholestasis</article-title>. <source>Nat. Commun.</source>
<volume>9</volume>, <fpage>1393</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03764-1</pub-id>
<pub-id pub-id-type="pmid">29643332</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>L.</given-names></name><name><surname>Trygg</surname><given-names>J.</given-names></name><name><surname>Wold</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>CV-ANOVA for significance testing of PLS and OPLS&#x000ae; models</article-title>. <source>J. Chemom. Soc.</source>
<volume>22</volume>, <fpage>594</fpage>&#x02013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1002/cem.1187</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Erlemann</surname><given-names>K.-R.</given-names></name><name><surname>Cossette</surname><given-names>C.</given-names></name><name><surname>Gravel</surname><given-names>S.</given-names></name><name><surname>Lesimple</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>G.-J.</given-names></name><name><surname>Saha</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress</article-title>. <source>Free Radic. Biol. Med.</source>
<volume>42</volume>, <fpage>654</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.12.006</pub-id>
<pub-id pub-id-type="pmid">17291989</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Erlemann</surname><given-names>K.-R.</given-names></name><name><surname>Rokach</surname><given-names>J.</given-names></name><name><surname>Powell</surname><given-names>W. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6, 8, 11, 14-eicosatetraenoic acid by inflammatory cells</article-title>. <source>J. Biol. Chem.</source>
<volume>279</volume>, <fpage>40376</fpage>&#x02013;<lpage>40384</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M401294200</pub-id>
<pub-id pub-id-type="pmid">15234979</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fiehn</surname><given-names>O.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabolomics by gas chromatography&#x02013;mass spectrometry: combined targeted and untargeted profiling</article-title>. <source>Curr. Protoc. Mol. Biol.</source>
<volume>114</volume>, <fpage>30.4.1</fpage>&#x02013;<lpage>30.4.32</lpage>. <pub-id pub-id-type="doi">10.1002/0471142727.mb3004s114</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Floegel</surname><given-names>A.</given-names></name><name><surname>Stefan</surname><given-names>N.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>M&#x000fc;hlenbruch</surname><given-names>K.</given-names></name><name><surname>Drogan</surname><given-names>D.</given-names></name><name><surname>Joost</surname><given-names>H.-G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach</article-title>. <source>Diabetes</source>
<volume>62</volume>, <fpage>639</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.2337/db12-0495</pub-id>
<pub-id pub-id-type="pmid">23043162</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fulco</surname><given-names>C.</given-names></name><name><surname>Rock</surname><given-names>P.</given-names></name><name><surname>Cymerman</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Maximal and submaximal exercise performance at altitude</article-title>. <source>Aviat. space, Environ. Med.</source>
<volume>69</volume>, <fpage>793</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="pmid">9715971</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>S.</given-names></name><name><surname>Chinnadurai</surname><given-names>V.</given-names></name><name><surname>Bhadra</surname><given-names>K.</given-names></name><name><surname>Gupta</surname><given-names>I.</given-names></name><name><surname>Kanwar</surname><given-names>R. S.</given-names></name></person-group> (<year>2022</year>). <article-title>Urinary metabolic modulation in human participants residing in Siachen: a 1H NMR metabolomics approach</article-title>. <source>Sci. Rep.</source>
<volume>12</volume>, <fpage>9070</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-13031-5</pub-id>
<pub-id pub-id-type="pmid">35641596</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Yue</surname><given-names>X.</given-names></name><name><surname>Hao</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Metabolomic analysis of human plasma sample after exposed to high altitude and return to sea level</article-title>. <source>PLoS One</source>
<volume>18</volume>, <fpage>e0282301</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0282301</pub-id>
<pub-id pub-id-type="pmid">36989280</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>G. E.</given-names></name><name><surname>Rokach</surname><given-names>J.</given-names></name><name><surname>Powell</surname><given-names>W. S.</given-names></name></person-group> (<year>2009</year>). <article-title>5-Oxo-ETE and the OXE receptor</article-title>. <source>Prostagl. Other Lipid Mediat.</source>
<volume>89</volume>, <fpage>98</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.prostaglandins.2009.05.002</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hay</surname><given-names>A.</given-names></name><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Gamboni</surname><given-names>F.</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M.</given-names></name><name><surname>Key</surname><given-names>A.</given-names></name><name><surname>Galbraith</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Sphingosine 1-phosphate has a negative effect on RBC storage quality</article-title>. <source>Blood Adv.</source>
<volume>7</volume>, <fpage>1379</fpage>&#x02013;<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2022008936</pub-id>
<pub-id pub-id-type="pmid">36469038</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hodun</surname><given-names>K.</given-names></name><name><surname>Chabowski</surname><given-names>A.</given-names></name><name><surname>Baranowski</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Sphingosine-1-phosphate in acute exercise and training</article-title>. <source>Scand. J. Med. Sci. Sports</source>
<volume>31</volume>, <fpage>945</fpage>&#x02013;<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1111/sms.13907</pub-id>
<pub-id pub-id-type="pmid">33345415</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>H&#x000f8;eg</surname><given-names>T. B.</given-names></name><name><surname>Chmiel</surname><given-names>K.</given-names></name><name><surname>Warrick</surname><given-names>A. E.</given-names></name><name><surname>Taylor</surname><given-names>S. L.</given-names></name><name><surname>Weiss</surname><given-names>R. H.</given-names></name></person-group> (<year>2020</year>). <article-title>Ultramarathon plasma metabolomics: phosphatidylcholine levels associated with running performance</article-title>. <source>Sports</source>
<volume>8</volume>, <fpage>44</fpage>. <pub-id pub-id-type="doi">10.3390/sports8040044</pub-id>
<pub-id pub-id-type="pmid">32244618</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horscroft</surname><given-names>J. A.</given-names></name><name><surname>Kotwica</surname><given-names>A. O.</given-names></name><name><surname>Laner</surname><given-names>V.</given-names></name><name><surname>West</surname><given-names>J. A.</given-names></name><name><surname>Hennis</surname><given-names>P. J.</given-names></name><name><surname>Levett</surname><given-names>D. Z.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Metabolic basis to Sherpa altitude adaptation</article-title>, <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>114</volume>, <fpage>6382</fpage>&#x02013;<lpage>6387</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1700527114</pub-id>
<pub-id pub-id-type="pmid">28533386</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horscroft</surname><given-names>J. A.</given-names></name><name><surname>Murray</surname><given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Skeletal muscle energy metabolism in environmental hypoxia: climbing towards consensus</article-title>. <source>Extr. Physiol. Med.</source>
<volume>3</volume>, <fpage>19</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1186/2046-7648-3-19</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Inc</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <source>MATLAB version: 9.13. 0 (R2022b)</source>. <publisher-loc>Natick, MA</publisher-loc>: <publisher-name>The MathWorks Inc</publisher-name>.</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jaguri</surname><given-names>A.</given-names></name><name><surname>AL Thani</surname><given-names>A. A.</given-names></name><name><surname>Elrayess</surname><given-names>M. A.</given-names></name></person-group> (<year>2023</year>). <article-title>Exercise metabolome: insights for health and performance</article-title>. <source>Metabolites</source>
<volume>13</volume>, <fpage>694</fpage>. <pub-id pub-id-type="doi">10.3390/metabo13060694</pub-id>
<pub-id pub-id-type="pmid">37367852</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>A. M.</given-names></name><name><surname>Carter</surname><given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>The effect of endurance training on parameters of aerobic fitness</article-title>. <source>Sports Med.</source>
<volume>29</volume>, <fpage>373</fpage>&#x02013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.2165/00007256-200029060-00001</pub-id>
<pub-id pub-id-type="pmid">10870864</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kabarowski</surname><given-names>J. H.</given-names></name></person-group> (<year>2009</year>). <article-title>G2A and LPC: regulatory functions in immunity</article-title>. <source>ProstaglOther Lipid Mediat.</source>
<volume>89</volume>, <fpage>73</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.prostaglandins.2009.04.007</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamphorst</surname><given-names>J. J.</given-names></name><name><surname>Cross</surname><given-names>J. R.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>DE Stanchina</surname><given-names>E.</given-names></name><name><surname>Mathew</surname><given-names>R.</given-names></name><name><surname>White</surname><given-names>E. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>110</volume>, <fpage>8882</fpage>&#x02013;<lpage>8887</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1307237110</pub-id>
<pub-id pub-id-type="pmid">23671091</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karliner</surname><given-names>J. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress</article-title>. <source>Biochim. Biophys. Acta (BBA)-Molecular Cell Biol. Lipids</source>
<volume>1831</volume>, <fpage>203</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2012.06.006</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawamata</surname><given-names>Y.</given-names></name><name><surname>Fujii</surname><given-names>R.</given-names></name><name><surname>Hosoya</surname><given-names>M.</given-names></name><name><surname>Harada</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>H.</given-names></name><name><surname>Miwa</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>AG protein-coupled receptor responsive to bile acids</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>9435</fpage>&#x02013;<lpage>9440</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M209706200</pub-id>
<pub-id pub-id-type="pmid">12524422</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.-W.</given-names></name><name><surname>Tchernyshyov</surname><given-names>I.</given-names></name><name><surname>Semenza</surname><given-names>G. L.</given-names></name><name><surname>Dang</surname><given-names>C. V.</given-names></name></person-group> (<year>2006</year>). <article-title>HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</article-title>. <source>Cell Metab.</source>
<volume>3</volume>, <fpage>177</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2006.02.002</pub-id>
<pub-id pub-id-type="pmid">16517405</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kind</surname><given-names>T.</given-names></name><name><surname>Wohlgemuth</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>D. Y.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Palazoglu</surname><given-names>M.</given-names></name><name><surname>Shahbaz</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry</article-title>. <source>Anal. Chem.</source>
<volume>81</volume>, <fpage>10038</fpage>&#x02013;<lpage>10048</lpage>. <pub-id pub-id-type="doi">10.1021/ac9019522</pub-id>
<pub-id pub-id-type="pmid">19928838</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirwan</surname><given-names>J. A.</given-names></name><name><surname>Gika</surname><given-names>H.</given-names></name><name><surname>Beger</surname><given-names>R. D.</given-names></name><name><surname>Bearden</surname><given-names>D.</given-names></name><name><surname>Dunn</surname><given-names>W. B.</given-names></name><name><surname>Goodacre</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management</article-title>. <source>Metabolomics</source>
<volume>18</volume>, <fpage>70</fpage>. <pub-id pub-id-type="doi">10.1007/s11306-022-01926-3</pub-id>
<pub-id pub-id-type="pmid">36029375</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Law</surname><given-names>S.-H.</given-names></name><name><surname>Chan</surname><given-names>M.-L.</given-names></name><name><surname>Marathe</surname><given-names>G. K.</given-names></name><name><surname>Parveen</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>C.-H.</given-names></name><name><surname>Ke</surname><given-names>L.-Y.</given-names></name></person-group> (<year>2019</year>). <article-title>An updated review of lysophosphatidylcholine metabolism in human diseases</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>20</volume>, <fpage>1149</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20051149</pub-id>
<pub-id pub-id-type="pmid">30845751</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lawler</surname><given-names>N. G.</given-names></name><name><surname>Abbiss</surname><given-names>C. R.</given-names></name><name><surname>Gummer</surname><given-names>J. P.</given-names></name><name><surname>Broadhurst</surname><given-names>D. I.</given-names></name><name><surname>Govus</surname><given-names>A. D.</given-names></name><name><surname>Fairchild</surname><given-names>T. J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Characterizing the plasma metabolome during 14 days of live&#x02010;high, train&#x02010;low simulated altitude: a metabolomic approach</article-title>. <source>Exp. Physiol.</source>
<volume>104</volume>, <fpage>81</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1113/EP087159</pub-id>
<pub-id pub-id-type="pmid">30311980</pub-id>
</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>G. D.</given-names></name><name><surname>Farrell</surname><given-names>L.</given-names></name><name><surname>Wood</surname><given-names>M. J.</given-names></name><name><surname>Martinovic</surname><given-names>M.</given-names></name><name><surname>Arany</surname><given-names>Z.</given-names></name><name><surname>Rowe</surname><given-names>G. C.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Metabolic signatures of exercise in human plasma</article-title>. <source>Sci. Transl. Med.</source>
<volume>2</volume>, <fpage>33ra37</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3001006</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liao</surname><given-names>W.-T.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Cui</surname><given-names>J.-H.</given-names></name><name><surname>Gao</surname><given-names>Y.-X.</given-names></name><name><surname>Liu</surname><given-names>F.-Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Metabolite modulation in human plasma in the early phase of acclimatization to hypobaric hypoxia</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>22589</fpage>. <pub-id pub-id-type="doi">10.1038/srep22589</pub-id>
<pub-id pub-id-type="pmid">26940428</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lima</surname><given-names>G.</given-names></name><name><surname>Shurlock</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Karanikolou</surname><given-names>A.</given-names></name><name><surname>Sutehall</surname><given-names>S.</given-names></name><name><surname>Pitsiladis</surname><given-names>Y. P.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Metabolomic profiling of recombinant erythropoietin (rHuEpo) in trained caucasian athletes</article-title>. <source>Clin. J. Sport Med.</source>
<volume>33</volume>, <fpage>e123</fpage>&#x02013;<lpage>e134</lpage>. <pub-id pub-id-type="doi">10.1097/JSM.0000000000001074</pub-id>
<pub-id pub-id-type="pmid">36731031</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhan</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>Z. B.</given-names></name><name><surname>Zhang</surname><given-names>E. L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>UPLC-QTOFMS-based metabolomic analysis of the serum of hypoxic preconditioning mice</article-title>. <source>Mol. Med. Rep.</source>
<volume>16</volume>, <fpage>6828</fpage>&#x02013;<lpage>6836</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2017.7493</pub-id>
<pub-id pub-id-type="pmid">28901489</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>S. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Glutathione synthesis</article-title>. <source>Biochim. Biophys. Acta (BBA)-General Subj.</source>
<volume>1830</volume>, <fpage>3143</fpage>&#x02013;<lpage>3153</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2012.09.008</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Metabolomic analysis of the plasma of patients with high-altitude pulmonary edema (HAPE) using 1H NMR</article-title>. <source>Mol. Biosyst.</source>
<volume>8</volume>, <fpage>1783</fpage>&#x02013;<lpage>1788</lpage>. <pub-id pub-id-type="doi">10.1039/c2mb25044f</pub-id>
<pub-id pub-id-type="pmid">22498880</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Preliminary study of patients with chronic mountain sickness by GC-TOF-MS based serum metabolomics analysis</article-title>. <source>Chin. J. Pathophysiol.</source>
<fpage>1676</fpage>&#x02013;<lpage>1682</lpage>.</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mancera-Soto</surname><given-names>E. M.</given-names></name><name><surname>Chamorro-Acosta</surname><given-names>M. L.</given-names></name><name><surname>Ramos-Caballero</surname><given-names>D. M.</given-names></name><name><surname>Torrella</surname><given-names>J. R.</given-names></name><name><surname>Cristancho-Mej&#x000ed;a</surname><given-names>E.</given-names></name></person-group> (<year>2022a</year>). <article-title>Effect of hypobaric hypoxia on hematological parameters related to oxygen transport, blood volume and oxygen consumption in adolescent endurance-training athletes</article-title>. <source>J. Exerc. Sci. Fit.</source>
<volume>20</volume>, <fpage>391</fpage>&#x02013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1016/j.jesf.2022.10.003</pub-id>
<pub-id pub-id-type="pmid">36348710</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mancera-Soto</surname><given-names>E. M.</given-names></name><name><surname>Ramos-Caballero</surname><given-names>D. M.</given-names></name><name><surname>Rojas J</surname><given-names>J. A.</given-names></name><name><surname>Duque</surname><given-names>L.</given-names></name><name><surname>Chaves-Gomez</surname><given-names>S.</given-names></name><name><surname>Cristancho-Mej&#x000ed;a</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2022b</year>). <article-title>Hemoglobin mass, blood volume and VO2max of trained and untrained children and adolescents living at different altitudes</article-title>. <source>Front. Physiology</source>
<volume>13</volume>, <fpage>892247</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2022.892247</pub-id>
</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mancera-Soto</surname><given-names>E.</given-names></name><name><surname>Ramos-Caballero</surname><given-names>D. M.</given-names></name><name><surname>Magalhaes</surname><given-names>J.</given-names></name><name><surname>Chaves Gomez</surname><given-names>S.</given-names></name><name><surname>Schmidt</surname><given-names>W. F.</given-names></name><name><surname>Cristancho&#x02010;Mej&#x000ed;a</surname><given-names>E.</given-names></name></person-group> (<year>2021</year>). <article-title>Quantification of testosterone&#x02010;dependent erythropoiesis during male puberty</article-title>. <source>Exp. Physiol.</source>
<volume>106</volume>, <fpage>1470</fpage>&#x02013;<lpage>1481</lpage>. <pub-id pub-id-type="doi">10.1113/EP089433</pub-id>
<pub-id pub-id-type="pmid">33945170</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendelson</surname><given-names>K.</given-names></name><name><surname>Evans</surname><given-names>T.</given-names></name><name><surname>Hla</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Sphingosine 1-phosphate signalling</article-title>. <source>Development</source>
<volume>141</volume>, <fpage>5</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1242/dev.094805</pub-id>
<pub-id pub-id-type="pmid">24346695</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monnerat</surname><given-names>G.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>C. A.</given-names></name><name><surname>Santos</surname><given-names>C. G.</given-names></name><name><surname>Paulucio</surname><given-names>D.</given-names></name><name><surname>Velasque</surname><given-names>R.</given-names></name><name><surname>Evaristo</surname><given-names>G. P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Different signatures of high cardiorespiratory capacity revealed with metabolomic profiling in elite athletes</article-title>. <source>Int. J. Spor. Physiol. Perform.</source>
<volume>15</volume>, <fpage>1156</fpage>&#x02013;<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.2019-0267</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Metabolic adaptation of skeletal muscle to high altitude hypoxia: how new technologies could resolve the controversies</article-title>. <source>Genome Med.</source>
<volume>1</volume>, <fpage>117</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1186/gm117</pub-id>
<pub-id pub-id-type="pmid">20090895</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muza</surname><given-names>S. R.</given-names></name><name><surname>Beidleman</surname><given-names>B. A.</given-names></name><name><surname>Fulco</surname><given-names>C. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Altitude preexposure recommendations for inducing acclimatization</article-title>. <source>High Alt. Med. Biol.</source>
<volume>11</volume>, <fpage>87</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2010.1006</pub-id>
<pub-id pub-id-type="pmid">20586592</pub-id>
</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Cendali</surname><given-names>F.</given-names></name><name><surname>Stefanoni</surname><given-names>D.</given-names></name><name><surname>Martinez</surname><given-names>J. L.</given-names></name><name><surname>Hansen</surname><given-names>K. C.</given-names></name><name><surname>San-Mill&#x000e1;n</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2023a</year>). <article-title>Metabolic signatures of performance in elite world tour professional male cyclists</article-title>. <source>Sports Med.</source>
<volume>53</volume>, <fpage>1651</fpage>&#x02013;<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-023-01846-9</pub-id>
<pub-id pub-id-type="pmid">37148487</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Cendali</surname><given-names>F.</given-names></name><name><surname>Stefanoni</surname><given-names>D.</given-names></name><name><surname>Martinez</surname><given-names>J. L.</given-names></name><name><surname>Hansen</surname><given-names>K. C.</given-names></name><name><surname>San-Mill&#x000e1;n</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2023b</year>). <article-title>Metabolic signatures of performance in elite world tour professional male cyclists</article-title>. <source>Sports Med.</source>
<volume>53</volume>, <fpage>1651</fpage>&#x02013;<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-023-01846-9</pub-id>
<pub-id pub-id-type="pmid">37148487</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Key</surname><given-names>A.</given-names></name><name><surname>Stephenson</surname><given-names>D.</given-names></name><name><surname>Earley</surname><given-names>E. J.</given-names></name><name><surname>Keele</surname><given-names>G. R.</given-names></name><name><surname>Hay</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title>. <source>Blood</source>
<volume>143</volume>, <fpage>2517</fpage>&#x02013;<lpage>2533</lpage>. <pub-id pub-id-type="doi">10.1182/blood.2024023983</pub-id>
<pub-id pub-id-type="pmid">38513237</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Skinner</surname><given-names>S. C.</given-names></name><name><surname>Nader</surname><given-names>E.</given-names></name><name><surname>Stefanoni</surname><given-names>D.</given-names></name><name><surname>Robert</surname><given-names>M.</given-names></name><name><surname>Cendali</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Acute cycling exercise induces changes in red blood cell deformability and membrane lipid remodeling</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume>, <fpage>896</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22020896</pub-id>
<pub-id pub-id-type="pmid">33477427</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Reisz</surname><given-names>J. A.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Dunham</surname><given-names>A.</given-names></name><name><surname>Wen</surname><given-names>E. Y.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Metabolism of citrate and other carboxylic acids in erythrocytes as a function of oxygen saturation and refrigerated storage</article-title>. <source>Front. Med.</source>
<volume>4</volume>, <fpage>175</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2017.00175</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Newsom</surname><given-names>S. A.</given-names></name><name><surname>Brozinick</surname><given-names>J. T.</given-names></name><name><surname>Kiseljak-Vassiliades</surname><given-names>K.</given-names></name><name><surname>Strauss</surname><given-names>A. N.</given-names></name><name><surname>Bacon</surname><given-names>S. D.</given-names></name><name><surname>Kerege</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans</article-title>. <source>J. Appl. Physiol.</source>
<volume>120</volume>, <fpage>1355</fpage>&#x02013;<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00664.2015</pub-id>
<pub-id pub-id-type="pmid">27032901</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>K. A.</given-names></name><name><surname>Atkinson</surname><given-names>R. A.</given-names></name><name><surname>Richardson</surname><given-names>L.</given-names></name><name><surname>Koulman</surname><given-names>A.</given-names></name><name><surname>Murray</surname><given-names>A. J.</given-names></name><name><surname>Harridge</surname><given-names>S. D.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp</article-title>. <source>Sci. Rep.</source>
<volume>9</volume>, <fpage>2297</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-38832-z</pub-id>
<pub-id pub-id-type="pmid">30783167</pub-id>
</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oestvang</surname><given-names>J.</given-names></name><name><surname>Johansen</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis</article-title>. <source>Biochim. Biophy. Acta (BBA)-Molecular Cell Biol. Lipids</source>
<volume>1761</volume>, <fpage>1309</fpage>&#x02013;<lpage>1316</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2006.06.003</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paglia</surname><given-names>G.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Rolfsson</surname><given-names>&#x000d3;.</given-names></name><name><surname>Sigurj&#x000f3;nsson</surname><given-names>&#x000d3;. E.</given-names></name><name><surname>Bordbar</surname><given-names>A.</given-names></name><name><surname>Palsson</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Biomarkers defining the metabolic age of red blood cells during cold storage</article-title>. <source>Blood, J. Am. Soc. Hematol.</source>
<volume>128</volume>, <fpage>e43</fpage>&#x02013;<lpage>e50</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2016-06-721688</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pardo-Rodriguez</surname><given-names>D.</given-names></name><name><surname>Santamar&#x000ed;a-Torres</surname><given-names>M.</given-names></name><name><surname>Salinas</surname><given-names>A.</given-names></name><name><surname>Jim&#x000e9;nez-Charris</surname><given-names>E.</given-names></name><name><surname>Mosquera</surname><given-names>M.</given-names></name><name><surname>Cala</surname><given-names>M. P.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Unveiling disrupted lipid metabolism in benign prostate hyperplasia, prostate cancer, and metastatic patients: insights from a Colombian Nested Case&#x02013;Control Study</article-title>. <source>Cancers</source>
<volume>15</volume>, <fpage>5465</fpage>. <pub-id pub-id-type="doi">10.3390/cancers15225465</pub-id>
<pub-id pub-id-type="pmid">38001725</pub-id>
</mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pichler Hefti</surname><given-names>J.</given-names></name><name><surname>Sonntag</surname><given-names>D.</given-names></name><name><surname>Hefti</surname><given-names>U.</given-names></name><name><surname>Risch</surname><given-names>L.</given-names></name><name><surname>Schoch</surname><given-names>O. D.</given-names></name><name><surname>Turk</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Oxidative stress in hypobaric hypoxia and influence on vessel-tone modifying mediators</article-title>. <source>High Alt. Med. Biol.</source>
<volume>14</volume>, <fpage>273</fpage>&#x02013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2012.1110</pub-id>
<pub-id pub-id-type="pmid">24067187</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pollard</surname><given-names>A. J.</given-names></name><name><surname>Niermeyer</surname><given-names>S.</given-names></name><name><surname>Barry</surname><given-names>P.</given-names></name><name><surname>B&#x000e4;rtsch</surname><given-names>P.</given-names></name><name><surname>Berghold</surname><given-names>F.</given-names></name><name><surname>Bishop</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Children at high altitude: an international consensus statement by an <italic>ad hoc</italic> committee of the International Society for Mountain Medicine, March 12, 2001</article-title>. <source>High Alt. Med. Biol.</source>
<volume>2</volume>, <fpage>389</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1089/15270290152608561</pub-id>
<pub-id pub-id-type="pmid">11682018</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prommer</surname><given-names>N.</given-names></name><name><surname>Schmidt</surname><given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>Loss of CO from the intravascular bed and its impact on the optimised CO-rebreathing method</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>100</volume>, <fpage>383</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-007-0439-2</pub-id>
<pub-id pub-id-type="pmid">17394011</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rabcuka</surname><given-names>J.</given-names></name><name><surname>Blonski</surname><given-names>S.</given-names></name><name><surname>Meli</surname><given-names>A.</given-names></name><name><surname>Sowemimo-Coker</surname><given-names>S.</given-names></name><name><surname>Zaremba</surname><given-names>D.</given-names></name><name><surname>Stephenson</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells</article-title>. <source>Blood Adv.</source>
<volume>6</volume>, <fpage>5415</fpage>&#x02013;<lpage>5428</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2022007774</pub-id>
<pub-id pub-id-type="pmid">35736672</pub-id>
</mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A.</given-names></name><name><surname>Bozi</surname><given-names>L. H.</given-names></name><name><surname>Yaghi</surname><given-names>O. K.</given-names></name><name><surname>Mills</surname><given-names>E. L.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Nicholson</surname><given-names>H. E.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>pH-gated succinate secretion regulates muscle remodeling in response to exercise</article-title>. <source>Cell</source>
<volume>183</volume>, <fpage>62</fpage>&#x02013;<lpage>75.e17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.08.039</pub-id>
<pub-id pub-id-type="pmid">32946811</pub-id>
</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rong</surname><given-names>L.</given-names></name><name><surname>Zeng</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group> (<year>2009</year>). <article-title>High-altitude hypoxia and liver injury</article-title>. <source>World Chin. J. Digestol.</source>
<volume>17</volume>, <fpage>2171</fpage>&#x02013;<lpage>2178</lpage>. <pub-id pub-id-type="doi">10.11569/wcjd.v17.i21.2171</pub-id>
</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>M. K.</given-names></name><name><surname>Wilkerson</surname><given-names>R. B.</given-names></name><name><surname>Alexander</surname><given-names>K.</given-names></name><name><surname>Nokoff</surname><given-names>N. J.</given-names></name><name><surname>Cree-Green</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>Longitudinal metabolic study of red blood cells from patients undergoing gender-affirming testosterone therapy</article-title>. <source>Blood Adv.</source>
<volume>7</volume>, <fpage>4269</fpage>&#x02013;<lpage>4277</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2022008061</pub-id>
<pub-id pub-id-type="pmid">36001490</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saltin</surname><given-names>B.</given-names></name><name><surname>Larsen</surname><given-names>H.</given-names></name><name><surname>Terrados</surname><given-names>N.</given-names></name><name><surname>Bangsbo</surname><given-names>J.</given-names></name><name><surname>Bak</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>C. K.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Aerobic exercise capacity at sea level and at altitude in Kenyan boys, junior and senior runners compared with Scandinavian runners</article-title>. <source>Scand. J. Med. Sci. Spor.</source>
<volume>5</volume>, <fpage>209</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.1995.tb00037.x</pub-id>
</mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>W.</given-names></name><name><surname>Prommer</surname><given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>The optimised CO-rebreathing method: a new tool to determine total haemoglobin mass routinely</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>95</volume>, <fpage>486</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-005-0050-3</pub-id>
<pub-id pub-id-type="pmid">16222540</pub-id>
</mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>W.</given-names></name><name><surname>Prommer</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Impact of alterations in total hemoglobin mass on VO<sub>2max</sub>
</article-title>. <source>Exerc Sport Sci. Rev.</source>
<volume>38</volume>, <fpage>68</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1097/JES.0b013e3181d4957a</pub-id>
<pub-id pub-id-type="pmid">20335738</pub-id>
</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semenza</surname><given-names>G. L.</given-names></name></person-group> (<year>2001</year>). <article-title>HIF-1 and mechanisms of hypoxia sensing</article-title>. <source>Curr. Opin. cell Biol.</source>
<volume>13</volume>, <fpage>167</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/s0955-0674(00)00194-0</pub-id>
<pub-id pub-id-type="pmid">11248550</pub-id>
</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semenza</surname><given-names>G. L.</given-names></name><name><surname>Roth</surname><given-names>P. H.</given-names></name><name><surname>Fang</surname><given-names>H.-M.</given-names></name><name><surname>Wang</surname><given-names>G. L.</given-names></name></person-group> (<year>1994</year>). <article-title>Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1</article-title>. <source>J. Biol. Chem.</source>
<volume>269</volume>, <fpage>23757</fpage>&#x02013;<lpage>23763</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(17)31580-6</pub-id>
<pub-id pub-id-type="pmid">8089148</pub-id>
</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Mohanty</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>A study of survival strategies for improving acclimatization of lowlanders at high-altitude</article-title>. <source>Heliyon</source>
<volume>9</volume>, <fpage>e14929</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e14929</pub-id>
<pub-id pub-id-type="pmid">37025911</pub-id>
</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Varshney</surname><given-names>R.</given-names></name><name><surname>Sethy</surname><given-names>N. K.</given-names></name></person-group> (<year>2022</year>). <article-title>Human adaptation to high altitude: a review of convergence between genomic and proteomic signatures</article-title>. <source>Hum. Genomics</source>
<volume>16</volume>, <fpage>21</fpage>. <pub-id pub-id-type="doi">10.1186/s40246-022-00395-y</pub-id>
<pub-id pub-id-type="pmid">35841113</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name><name><surname>Stillman</surname><given-names>M. J.</given-names></name><name><surname>Lieberman</surname><given-names>H. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Tyrosine administration prevents hypoxia-induced decrements in learning and memory</article-title>. <source>Physiol. Behav.</source>
<volume>59</volume>, <fpage>867</fpage>&#x02013;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9384(95)02107-8</pub-id>
<pub-id pub-id-type="pmid">8778879</pub-id>
</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sibomana</surname><given-names>I.</given-names></name><name><surname>Foose</surname><given-names>D. P.</given-names></name><name><surname>Raymer</surname><given-names>M. L.</given-names></name><name><surname>Reo</surname><given-names>N. V.</given-names></name><name><surname>Karl</surname><given-names>J. P.</given-names></name><name><surname>Berryman</surname><given-names>C. E.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Urinary metabolites as predictors of acute mountain sickness severity</article-title>. <source>Front. Physiol.</source>
<volume>12</volume>, <fpage>709804</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.709804</pub-id>
<pub-id pub-id-type="pmid">34588992</pub-id>
</mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siervo</surname><given-names>M.</given-names></name><name><surname>Riley</surname><given-names>H. L.</given-names></name><name><surname>Fernandez</surname><given-names>B. O.</given-names></name><name><surname>Leckstrom</surname><given-names>C. A.</given-names></name><name><surname>Martin</surname><given-names>D. S.</given-names></name><name><surname>Mitchell</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Effects of prolonged exposure to hypobaric hypoxia on oxidative stress, inflammation and gluco-insular regulation: the not-so-sweet price for good regulation</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e94915</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094915</pub-id>
<pub-id pub-id-type="pmid">24733551</pub-id>
</mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>M. H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><name><surname>Ko</surname><given-names>T.-P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease</article-title>. <source>Sci. Rep.</source>
<volume>7</volume>, <fpage>15281</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-13667-8</pub-id>
<pub-id pub-id-type="pmid">29127281</pub-id>
</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name><name><surname>Nemkov</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia</article-title>. <source>Nat. Commun.</source>
<volume>7</volume>, <fpage>12086</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12086</pub-id>
<pub-id pub-id-type="pmid">27417539</pub-id>
</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Shinjo</surname><given-names>S.</given-names></name><name><surname>Arai</surname><given-names>T.</given-names></name><name><surname>Kanai</surname><given-names>M.</given-names></name><name><surname>Goda</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Hypoxia and fatty liver</article-title>. <source>World J. Gastroenterol.</source>
<volume>20</volume>, <fpage>15087</fpage>&#x02013;<lpage>15097</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i41.15087</pub-id>
<pub-id pub-id-type="pmid">25386057</pub-id>
</mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tannahill</surname><given-names>G.</given-names></name><name><surname>Curtis</surname><given-names>A.</given-names></name><name><surname>Adamik</surname><given-names>J.</given-names></name><name><surname>Palsson-Mcdermott</surname><given-names>E.</given-names></name><name><surname>Mcgettrick</surname><given-names>A.</given-names></name><name><surname>Goel</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Succinate is an inflammatory signal that induces IL-1&#x003b2; through HIF-1&#x003b1;</article-title>. <source>Nature</source>
<volume>496</volume>, <fpage>238</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1038/nature11986</pub-id>
<pub-id pub-id-type="pmid">23535595</pub-id>
</mixed-citation></ref><ref id="B92"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Tanner</surname><given-names>J.</given-names></name></person-group> (<year>1962</year>). <source>Growth at adolescence</source>. <publisher-loc>Oxford, England</publisher-loc>: <publisher-name>Blackwell Scientific Publications</publisher-name>.</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Travis</surname><given-names>N.</given-names></name><name><surname>Kaiqi</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>L.</given-names></name><name><surname>Anren</surname><given-names>S.</given-names></name><name><surname>Daniel</surname><given-names>D.</given-names></name><name><surname>Sruti</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>AltitudeOmics: red blood cell metabolic adaptation to high altitude hypoxia</article-title>. <source>J. Proteome Res.</source>
<volume>15</volume>, <fpage>3883</fpage>&#x02013;<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00733</pub-id>
<pub-id pub-id-type="pmid">27646145</pub-id>
</mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Der Pol</surname><given-names>A.</given-names></name><name><surname>Gil</surname><given-names>A.</given-names></name><name><surname>Tromp</surname><given-names>J.</given-names></name><name><surname>Sillje</surname><given-names>H. H.</given-names></name><name><surname>VAN Veldhuisen</surname><given-names>D. J.</given-names></name><name><surname>Voors</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction</article-title>. <source>Cardiovasc. Res.</source>
<volume>114</volume>, <fpage>1871</fpage>&#x02013;<lpage>1882</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvy187</pub-id>
<pub-id pub-id-type="pmid">30032247</pub-id>
</mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallner</surname><given-names>S.</given-names></name><name><surname>Schmitz</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Plasmalogens the neglected regulatory and scavenging lipid species</article-title>. <source>Chem. Phys. Lipids</source>
<volume>164</volume>, <fpage>573</fpage>&#x02013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2011.06.008</pub-id>
<pub-id pub-id-type="pmid">21723266</pub-id>
</mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.-D.</given-names></name><name><surname>Chen</surname><given-names>W.-D.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Forman</surname><given-names>B. M.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-&#x003ba;B) in mice</article-title>. <source>Hepatology</source>
<volume>54</volume>, <fpage>1421</fpage>&#x02013;<lpage>1432</lpage>. <pub-id pub-id-type="doi">10.1002/hep.24525</pub-id>
<pub-id pub-id-type="pmid">21735468</pub-id>
</mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>West</surname><given-names>J. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Recent advances in high altitude medicine and biology</article-title>. <source>High. Alt. Med. Biol.</source>
<volume>16</volume>, <fpage>73</fpage>. <pub-id pub-id-type="doi">10.1089/ham.2015.28999.jbw</pub-id>
<pub-id pub-id-type="pmid">25961356</pub-id>
</mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Bogdanov</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Hypoxia-mediated impaired erythrocyte Lands&#x02019; Cycle is pathogenic for sickle cell disease</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>29637</fpage>. <pub-id pub-id-type="doi">10.1038/srep29637</pub-id>
<pub-id pub-id-type="pmid">27436223</pub-id>
</mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xavier</surname><given-names>R.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>C.</given-names></name><name><surname>Paulucio</surname><given-names>D.</given-names></name><name><surname>Da Silva</surname><given-names>I. M.</given-names></name><name><surname>Velasque</surname><given-names>R.</given-names></name><name><surname>Nogueira</surname><given-names>F. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A multidimensional approach to assessing anthropometric and aerobic fitness profiles of elite Brazilian endurance athletes and military personnel</article-title>. <source>Mil. Med.</source>
<volume>184</volume>, <fpage>875</fpage>&#x02013;<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1093/milmed/usz003</pub-id>
<pub-id pub-id-type="pmid">30941410</pub-id>
</mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>B. C.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis</article-title>. <source>Cell Metab.</source>
<volume>34</volume>, <fpage>299</fpage>&#x02013;<lpage>316. e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2021.12.019</pub-id>
<pub-id pub-id-type="pmid">35108516</pub-id>
</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.-C.</given-names></name><name><surname>Hsiao</surname><given-names>L.-D.</given-names></name><name><surname>Su</surname><given-names>M.-H.</given-names></name><name><surname>Yang</surname><given-names>C.-M.</given-names></name></person-group> (<year>2020</year>). <article-title>Sphingosine 1-phosphate induces cyclooxygenase-2/prostaglandin E2 expression via PKC&#x003b1;-dependent mitogen-activated protein kinases and NF-&#x003ba;B cascade in human cardiac fibroblasts</article-title>. <source>Front. Pharmacol.</source>
<volume>11</volume>, <fpage>569802</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.569802</pub-id>
<pub-id pub-id-type="pmid">33192511</pub-id>
</mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Cruickshank</surname><given-names>C.</given-names></name><name><surname>Armstrong</surname><given-names>M.</given-names></name><name><surname>Mahaffey</surname><given-names>S.</given-names></name><name><surname>Reisdorph</surname><given-names>R.</given-names></name><name><surname>Reisdorph</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>New sample preparation approach for mass spectrometry-based profiling of plasma results in improved coverage of metabolome</article-title>. <source>J. Chromatogr. A</source>
<volume>1300</volume>, <fpage>217</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2013.04.030</pub-id>
<pub-id pub-id-type="pmid">23672979</pub-id>
</mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Vidalino</surname><given-names>L.</given-names></name><name><surname>Anesi</surname><given-names>A.</given-names></name><name><surname>Macchi</surname><given-names>P.</given-names></name><name><surname>Guella</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>A lipidomics investigation of the induced hypoxia stress on HeLa cells by using MS and NMR techniques</article-title>. <source>Mol. Biosyst.</source>
<volume>10</volume>, <fpage>878</fpage>&#x02013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1039/c3mb70540d</pub-id>
<pub-id pub-id-type="pmid">24496110</pub-id>
</mixed-citation></ref></ref-list></back></article>